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Abstract 
Early embryonic development in vertebrates is directed in part by maternal mRNAs 
expressed in oocytes and stored in cytoplasmic messenger ribonucleoprotein particles (mRNPs).  
Abundant evidence demonstrates the importance of mRNPs in embryonic development and in 
post-embryonic cellular function; however their characterization has been hampered by lack of 
suitable methodologies.  The Xenopus oocyte has been the primary model system for studies of 
mRNPs.  YY1 is a well-studied transcriptional regulatory factor that is sequestered in the oocyte 
cytoplasm and present entirely in cytoplasmic oocyte mRNPs.  The objective of this thesis was to 
examine the biochemistry of YY1 association with maternal mRNA molecules in order to shed 
light on the role of YY1 in development and the poorly understood biology of oocyte mRNPs.  
The initial working hypotheses were that association of YY1 with mRNPs is dependent on 
sequence-specific RNA-binding activity and, therefore, that YY1 associates with a definite 
subset of maternal mRNA.  A number of unique methods were developed in this study to address 
these hypotheses.  RNA immunoprecipitation-DNA microarray (RIP-CHIP) analysis establishes 
that YY1 associates with a subset of mRNAs in the oocyte pool.  A novel sequence-specific 
RNA-binding activity of the YY1 protein is demonstrated, and the RNA-binding activity of YY1 
is shown to be required for its association with oocyte mRNPs in vivo.  The functional roles of 
YY1 mRNA substrates are discussed in the context of embryological development and the 
biological function of YY1 in oocyte mRNPs.  Extension of the experimental approaches 
developed in this thesis to the entire set of mRNP proteins would significantly advance our 
understanding of mRNP composition and heterogeneity, as well as the biological function of 
maternal mRNAs and mRNPs in development. 
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1.  Introduction - Embryonic development in metazoans is highly dependent on mRNA 
transcribed during oogenesis and translated in the embryo following fertilization to provide 
protein products required for differentiation and development (Brandhorst, 1985; Dworkin and 
Dworkin-Rastl, 1990; Evans and Hunter, 2005; Evsikov and Marin de Evsikova, 2009; Farley 
and Ryder, 2008; Gosden, 2002; Grainger, 1994; Heasman, 2006; Li et al., 2010; Pederson, 
2006; Richter, 1991; Sardet et al., 2007; Semotok and Lipshitz, 2007; Tadros and Lipshitz, 
2009).  These transcripts are termed maternal mRNA in reference to their origin via transcription 
of the diploid genome of the female animal.  These mRNA molecules persist through meiosis 
and fertilization and subsequently are utilized at specific developmental stages and cellular 
lineages (Bravo and Knowland, 1979; King et al., 2005; Laskey and Gurdon, 1974; Melton et al., 
1989; Woodland et al., 1979).  In all metazoans, stability and cell- and stage-specific translation 
of maternal mRNA throughout the protracted period of oogenesis and embryonic development is 
mediated by interaction with cytoplasmic RNA-binding proteins in complexes termed messenger 
ribonucleoprotein particles (mRNPs) (Smith and Richter, 1985; Sommerville, 1990; Spirin, 
1966).  The major model system for the study of maternal mRNA, mRNPs, and their role in 
embryonic development is the African Clawed Frog, Xenopus laevis (Dreyfuss et al., 2002; 
Grainger, 1994; Hake and Richter, 1997; Heasman, 2006; King et al., 2005; Kloc et al., 2001; 
Matsumoto and Wolffe, 1998; Melton et al., 1989; Richter, 1991; Richter et al., 1990; 
Sommerville, 1990; Sommerville, 1999).  Yin-Yang 1 (YY1), a protein factor indispensable in 
Xenopus embryogenesis (Kwon and Chung, 2003; Morgan et al., 2004; Satijn et al., 2001), is 
sequestered entirely in cytoplasmic mRNP complexes in oocytes and early embryos (Ficzycz et 
al., 2001; Ficzycz and Ovsenek, 2002).  However, the mechanisms by which YY1 associates with 
maternal mRNA and mRNA content of YY1 containing mRNP complexes had not been 
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determined.  The current study employs a number of novel approaches to demonstrate that YY1 
associates with maternal mRNA in vivo via an RNA-binding activity of the YY1 protein and 
identifies the mRNA population present in YY1 containing mRNP complexes. 
1.1 Embryonic Development of Xenopus laevis and Cytoplasmic Messenger 
Ribonucleoprotein Par ticles – Xenopus laevis has long been a major model system in 
developmental biology.  The large numbers of oocytes or embryos which can be obtained from a 
single female frog, the ease of in vitro fertilization, maintenance of oocytes and embryos in 
simple salt solutions, and development of the embryo outside the female have ensured the 
continued success of the Xenopus model system.  Furthermore, the availability and size (0.05-2 
mm) of Xenopus oocytes and embryos provide large quantities of nucleic acid and protein 
material for biochemical studies.  Oogenesis and embryogenesis in Xenopus have been fully 
characterized morphologically (Dumont, 1972; Nieuwkoop and Faber, 1967).  Dumont (Dumont, 
1972) divided oogenesis into six distinct stages based on morphological criteria which are 
denoted by Roman numerals I to VI (embryonic stages are denoted by Arabic numerals).  As 
oogenesis progresses from stage I to stage VI the oocyte increases from 50 µm to 1.3 mm in 
diameter, with an accompanying increase in cellular volume of 0.91 mm3 (Dumont, 1972).  This 
increased volume is occupied by a variety of materials which accumulate in the oocyte and are 
utilized later in development to provide amino acids, carbohydrates, and lipids; metabolic 
energy; cellular organelles and structural components; and, importantly, proteins required for 
embryogenesis and differentiation (Smith and Richter, 1985).  Some protein products required 
later in embryogenesis accumulate in the oocyte, however, the majority of proteins utilized in 
early development arise by translation of mRNA transcribed in the oocyte and stored in mRNP 
complexes (Smith and Richter, 1985; Sommerville, 1990; Spirin, 1966). 
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In Xenopus, oogenesis typically lasts 6 – 8 months, during which time the oocyte remains 
arrested in a prolonged prophase of meiosis I whilst various materials required for later 
development accumulate.  Maternal mRNA transcribed during this period is sufficient to direct 
development of the embryo up until the mid-blastula transition (MBT) at which point 
transcription from the zygotic genome begins (Davidson, 1986; Davidson and Hough, 1971).  
The role of maternal mRNA extends well beyond MBT with translation of maternal mRNA 
occurring in conjunction with gastrulation, neurulation, and organogenesis (Bravo and 
Knowland, 1979; Laskey and Gurdon, 1974; Woodland et al., 1979).  This has been 
demonstrated most conclusively using androgenic haploid embryos produced by fertilization of 
enucleated Xenopus laevis oocytes with sperm of Xenopus borealis, wherein newly synthesized 
transcripts are derived from the X. borealis genome and can be distinguished from maternal X. 
laevis transcripts in northern blots (Woodland et al., 1979).  In this system maternal mRNAs 
were found to be stable for long periods, then rapidly entered the unstable mRNA pool at MBT 
and gastrulation (Woodland et al., 1979).  Bursts of protein synthesis were also observed in 
connection with MBT, gastrulation, and neurulation in embryos treated with pharmacologic 
inhibitors of transcription, indicating the required transcripts were recruited from the stored pool 
(Allende et al., 1974; Bravo and Knowland, 1979; Laskey and Gurdon, 1974).  Transcription of 
maternal mRNA reaches its maximum level at stages III – IV of oogenesis, coinciding with the 
appearance of mature lamp brush chromosomes due to decondensation of nuclear chromatin 
(Ficq, 1970; Hill and Macgregor, 1980; Pardue and Gall, 1969; Thomas, 1970).  Accumulation of 
RNA in the cytoplasm proceeds at a rate of 1.7-2.2 pg/min (Anderson et al., 1982) until the 
completion of oogenesis at stage VI when oocytes contain approximately 4.3 µg of RNA 
(Rosbash, 1974).  Of the total amount of RNA in the mature oocyte, 0.7 – 1.0 % (~40 ng) is 
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poly-A+ RNA, while ribosomal RNA comprises the major portion of the remainder (Rosbash, 
1974).  Approximately 20 % of cytoplasmic mRNA in stage VI oocytes is present in 
polyribosomes, the other 80 % being present as stored mRNA in mRNPs (Smith and Richter, 
1985).  Messenger ribonucleoprotein particles contain polyadenylated nuclear transcripts and 
exclude transcripts from the mitochondrial genome, since studies show only synthetic mRNAs 
injected in the nucleus are capable of entering the mRNP  pool (Braddock et al., 1994).  Some 
mRNP proteins, for example Xp54 (see below) have been localized to active areas of 
transcription in immature oocytes by immunoelectron microscopy and immunocytochemical 
methods  (Smillie and Sommerville, 2002; Weston and Sommerville, 2006).  These data suggest 
assembly of mRNP complexes begins concomitant with transcription of maternal mRNA and 
complex formation is necessary for nuclear export of maternal mRNA destined for the mRNP 
pool (Braddock et al., 1994; Smillie and Sommerville, 2002; Weston and Sommerville, 2006).  
A number of protein factors essential for Xenopus development have been identified in 
Xenopus oocyte mRNP particles, including four major proteins abundantly present in mRNP 
complexes: Xp54, FRGY2A, FRGY2B, and RAP55  (Belak et al., 2008; Belak and Ovsenek, 
2007; Bouvet et al., 1995; Bouvet and Wolffe, 1994; Brzostowski et al., 2000; Evans and Hunter, 
2005; Ficzycz et al., 2001; Ficzycz and Ovsenek, 2002; Ladomery et al., 1997; Lieb et al., 1998; 
Marello et al., 1992; Marnef et al., 2009; Matsumoto et al., 2000; Minshall and Standart, 2004; 
Minshall et al., 2001; Moore, 2005; Smillie and Sommerville, 2002; Sommerville, 1990; Tanaka 
et al., 2006; Weston and Sommerville, 2006; Yurkova and Murray, 1997), and a number of 
significantly less abundant proteins including CIRP2 (Matsumoto et al., 2000), CBTF 
(Brzostowski et al., 2000), p100 (Nakamura et al., 2010), Vg1RBP (Git and Standart, 2002; 
Kwon et al., 2002), Xstau1 (Allison et al., 2004), and YY1 (Ficzycz and Ovsenek, 2002).  Some 
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of these, such as Vg1RBP and Xstau1, have been shown to be required for localization of 
substrate mRNAs (Allison et al., 2004; Git and Standart, 2002; Kwon et al., 2002), however, the 
precise developmental roles of the other known mRNP proteins remain poorly understood.  The 
stoichiometry and physical structure of mRNPs are currently uncharacterized.  Therefore, it is 
unknown if the high abundance of the major mRNP proteins is due to many molecules of these 
proteins associating with each mRNA while only one or a very few of the less abundant proteins 
associate with each transcript. Alternatively, the abundant mRNP proteins may be present 
ubiquitously in all mRNP particles while the other less abundant proteins are bound to only a 
subset of the total mRNAs in the mRNP pool, as is the case for Vg1RBP and Xstau1 (Allison et 
al., 2004; Git and Standart, 2002; Kwon et al., 2002).  Importantly, the mechanisms by which 
specific mRNA molecules are recruited from the mRNP pool at specific developmental time 
points and in specific cell types is unknown.  The currently accepted theory is that Xp54, 
FRGY2A/B, and RAP55 from the “core” compliment of mRNP proteins while other less 
abundant proteins likely bind a subset of mRNP-associated mRNA and underlie the 
spatiotemporal translational recruitment of specific mRNA molecules (Farley and Ryder, 2008; 
Marnef et al., 2009; Standart and Minshall, 2008; Tanaka et al., 2006; Weston and Sommerville, 
2006).   
 Xp54 is the Xenopus homologue of the human DEAD-box ATP-dependent RNA helicase 
p54 (Ladomery et al., 1997).  Mammalian p54 has roles in a number of processes in mRNA 
metabolism including transcription, mRNA splicing and editing, translation initiation, nuclear 
export, and degradation (Lorsch, 2002).  In Xenopus, photocrosslinking of [α-32P]ATP to mRNPs 
in solution resulted in covalent labelling of a 54 kDa polypeptide (Ladomery et al., 1997).  
Cyanogen bromide digestion of this polypeptide and partial sequencing of the resulting peptide 
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fragments permitted cloning of Xenopus p54 by PCR using degenerate primers (Ladomery et al., 
1997).  Subsequent sequence alignment analysis demonstrated that Xp54 belongs to the DEAD-
box RNA helicase family (Ladomery et al., 1997) which includes human p54 (Lu and Yunis, 
1992), mouse p54 (Akao et al., 1995), Drosophila ME31B (de Valoir et al., 1991), S. pombe 
Ste13 (Maekawa et al., 1994), and S. cerevisiae DHH1 (Strahl-Bolsinger and Tanner, 1993).  
Immunocytochemical studies indicate Xp54 is most abundant in the nucleus in early oocytes and 
becomes progressively localized to the cytoplasm as oogenesis proceeds (Smillie and 
Sommerville, 2002).  Furthermore, Xp54 appears to associate with areas of active transcription 
on lamp brush chromosomes in early oocytes, suggesting it associated with maternal mRNA 
concomitant with its transcription and then accompanies these mRNAs during nuclear export and 
into mRNPs (Smillie and Sommerville, 2002).  Density gradient centrifugation shows Xp54 co-
sediments with FRGY2A/B (Ladomery et al., 1997) in an RNA-dependent manner and Xp54 has 
been detected in mRNPs isolated by oligo-dT cellulose chromatography of oocyte lysates 
(Tanaka et al., 2006).         
FRGY2A and FRGY2B are germ-line specific members of the Cold-Shock Doman 
containing Y-box protein family which includes the well-characterized homologous human YB-1 
and rabbit p50 proteins (Richter and Smith, 1984).  The p50 protein was the first Y-box protein to 
be discovered and characterized, initially in rabbit reticulocytes where it regulates translation and 
stability of globin mRNA (Minich et al., 1993).  FRGY2A and FRGY2B are closely related 
polypeptides (85 % homology) originally identified by SDS-PAGE analysis of isolated mRNP 
particles (Darnbrough and Ford, 1981), and may represent the products of pseudoalleles in 
Xenopus (Murray et al., 1992).  FRGY2A/B, their somatic paralogue FRGY1, and the human 
orthologue YB-1 possess dual functional roles, as transcription factors, and as cytoplasmic RNA-
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binding proteins (Evdokimova et al., 2006; Evdokimova and Ovchinnikov, 1999; Evdokimova et 
al., 1995; Kohno et al., 2003; Minich and Ovchinnikov, 1992).  Interestingly, this dual DNA- and 
RNA-binding activity is shared with the other mRNP proteins CBTF (Brzostowski et al., 2000) 
and YY1 (Belak et al., 2008; Belak and Ovsenek, 2007) (see below).  In oocytes, FRGY2A/B 
bind to single-stranded RNA and have been shown to play an essential role in masking and 
translational silencing of maternal mRNA molecules (Bouvet and Wolffe, 1994; Deschamps et 
al., 1991; Deschamps et al., 1992; Marello et al., 1992; Murray, 1994; Murray et al., 1992; 
Ranjan et al., 1993; Tafuri and Wolffe, 1990; Tafuri and Wolffe, 1993a; Tafuri and Wolffe, 
1993b; Yurkova and Murray, 1997).  Maximum levels of FRGY2A/B are achieved by stage II of 
oogenesis, however the majority of the protein is present as the monomer (Tafuri and Wolffe, 
1993b).  Coinciding with the accumulation of maternal mRNA in stages III – IV, FRGY2A/B 
protein is progressively incorporated into mRNP particles, and by stage VI mRNPs contain the 
entire cellular compliment of FRGY2A/B (Tafuri and Wolffe, 1993b).  Reconstitution 
experiments demonstrated FRGY2A/B represses translation of mRNA templates in vitro (Kick et 
al., 1987; Matsumoto et al., 1996; Ranjan et al., 1993; Richter and Smith, 1984; Yurkova and 
Murray, 1997), and microinjection of oocytes with function-blocking anti-FRGY2A/B antibodies 
relieved translational silencing mediated by FRGY2A/B (Braddock et al., 1994; Gunkel et al., 
1995).  Collectively, these data demonstrate the role of FRGY2A/B in translational repression of 
stored maternal mRNA.  FRGY2A/B and the current study focussing on YY1 represent similar 
paradigms since both were originally described as transcription factors that were subsequently 
discovered in Xenopus oocyte mRNPs.        
RAP55 (RNA-associated protein 55 kDa) is the most recent major mRNP protein to be 
identified (Lieb et al., 1998).  It appears to interact with maternal mRNA via two RGG domains 
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located in the C-terminal region of the protein (Lieb et al., 1998) although protein-protein 
interactions may also play a role in its association with maternal mRNA (Lieb et al., 1998; 
Tanaka et al., 2006).  RAP55 is known to repress translation of substrate mRNA molecules in 
somatic cells by interacting with the cytoplasmic polyadenylation element binding protein 
(CPEB) and thereby blocking cytoplasmic polyadenylation and the resulting translational 
activation (Marnef et al., 2009; Yang et al., 2006).  Tethering of MS2-RAP55 fusion proteins to 
mRNA synthesized in vitro resulted in reduced translation in vivo and in vitro suggesting a 
similar role for RAP55 in oocyte mRNPs (Tanaka et al., 2006).  Overall, evidence suggests that 
FRGY2A/B and RAP55 are primarily responsible for translational repression of mRNP-
associated mRNA while Xp54 is inactive in mRNPs and plays a role in translational recruitment 
of associated mRNA molecules through activation of its helicase activity by phosphorylation 
(Ladomery et al., 1997; Minshall and Standart, 2004; Minshall et al., 2001; Sommerville and 
Ladomery, 1996). 
The history of the discovery of Vg1RBP differs significantly from other mRNP proteins.  
Initially, comparison of cDNA libraries generated from mRNA isolated from animal and vegetal 
poles of the oocyte revealed the transcript Vg1 was localized to the vegetal pole (Rebagliati et 
al., 1985).  Subsequent Northern blotting revealed Vg1 was highly concentrated in the vegetal 
pole of the oocyte and retained this localization following fertilization (Rebagliati et al., 1985).  
Vg1 was subsequently shown to be a strong inducer of endodermal tissues (Henry et al., 1996).  
Mutational analysis revealed deletion of a 340 nucleotide sequence in the 3’UTR of Vg1, later 
termed the vegetal localization element (VLE), resulted in disruption of endoderm formation due 
to mislocalization of Vg1 mRNA (Joseph and Melton, 1997; Mowry and Melton, 1992).  This 
prompted the search for protein factors that might interact with the VLE sequence and potentially 
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underlie localization of the Vg1 mRNA.  Photocrosslinking followed by RNase T1 treatment of 
in vitro binding reactions containing oocyte lysate and radiolabelled VLE identified a 68 kDa 
polypeptide interacting with the VLE (Schwartz et al., 1992).  This polypeptide was 
subsequently sequenced, characterized, and shown to underlie the localization of VLE-
containing maternal mRNAs to the vegetal cytoplasm, and was ultimately given the designation 
Vg1-RNA binding protein (Vg1RBP)  (Git and Standart, 2002).  The identification of Vg1RBP 
in mRNPs was based on the search for protein factors responsible for a specific developmental 
effect, namely, the crucial localization of certain mRNAs to the vegetal cytoplasm of the oocyte.  
This is in contrast to the situation with other mRNP proteins, such as YY1.  The mRNP proteins 
discussed above, and specifically YY1, are known to play essential roles in development (see 
below), however, the mechanism by which these effects are manifested, and the specific mRNA 
substrates potentially targeted and/or regulated during development through interaction with 
these factors is unknown.  Therefore, the aim of the current study is to analyze the biochemical 
mechanism by which YY1 associates with maternal mRNA in mRNPs and identify the specific 
mRNA substrates of YY1 in mRNPs.  This knowledge will provide a basis on which to further 
elucidate the role of YY1 in early vertebrate development. 
1.2 YY1 Protein: Review of Literature to Date - Yin Yang 1 (YY1) is one of the most 
well-known transcription factors and the vertebrate protein has been the subject of over 750 
scholarly articles.  However, the role of YY1 in development has not been extensively studied.  
YY1  is a highly conserved transcription factor of the GLI-Kruppel family with functions in 
activation, repression, or initiation of transcription at a number of cellular and viral promoters 
depending on the cellular context (Galvin and Shi, 1997; Gordon et al., 2006; Ladomery and 
Dellaire, 2002; Shi et al., 1997; Thomas and Seto, 1999; Wang et al., 2006).  The activity of 
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YY1 is modified by numerous interactions with other proteins including c-Myc (Shrivastava et 
al., 1993), Sp1 (Lee et al., 1994; Seto et al., 1993), the polycomb group protein EED (Satijn et 
al., 2001), cAMP response element binding protein (O'Connor et al., 1996), the viral protein E1A 
(Shi et al., 1991), retinoblastoma protein (Petkova et al., 2001), the GATA1 transcription factor 
(Rincon-Arano et al., 2005), and the specific activator YY1AP (Wang et al., 2004).  YY1 is 
subject to posttranslational modifications such as glycosylation (Hiromura et al., 2003; Ozcan et 
al., 2010), acetylation (Yao et al., 2001), and phosphorylation (Becker et al., 1994).  Regulation 
of the transcriptional activity of YY1 is also achieved through nucleocytoplasmic redistribution 
of the protein (Bernard and Voisin, 2008; Broyles et al., 1999; Favot et al., 2005; Krippner-
Heidenreich et al., 2005; Oh and Broyles, 2005; Palko et al., 2004; Rylski et al., 2008; Seligson 
et al., 2005; Shestakova et al., 2004; Slezak et al., 2004).  The main structural features of YY1 
are shown diagrammatically in Figure 1.  YY1 contains four C2H2-type zinc fingers near the C-
terminus responsible for YY1 DNA binding activity (Austen et al., 1997), a bipartite activation 
domain near the N-terminus (Austen et al., 1997), and a transcriptional repression domain near 
the C-terminus (Bushmeyer et al., 1995). The Xenopus laevis homologue is a 43 kDa, 373 amino 
acid protein sharing  
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Figure 1 - Domain Structure of YY1. The amino acid sequence of the Xenopus YY1 protein is 
presented in FASTA format and important structural features are highlighted. The Zinc 
finger/DNA binding region is underlined in blue. The four C2H2 type zinc fingers are 
individually highlighted in green along with the key cysteine and histidine residues responsible 
for coordination of zinc ions. The second zinc finger shows close homology with the known 
RNA-binding protein TFIIIA and is indicated with an asterisk. The N-terminal bipartite 
transcriptional activation domain is underlined in red. The C-terminal transcriptional repression 
domain overlaps the last two zinc fingers and is underlined in dashed yellow.  
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a high degree of sequence and structural conservation with mammalian YY1 (86 % similar 
relative to Human YY1) (Pisaneschi et al., 1994).   
Cytoplasmic redistribution of YY1 was first observed in connection with vaccinia virus 
infection (Broyles et al., 1999).  Immunofluorescence, immunoprecipitation, and gel-shift 
analyses indicate YY1 is rapidly redistributed to the cytoplasm following vaccinia virus infection 
where it participates in cytoplasmic transcription of viral genes in concert with viral protein 
factors (Broyles et al., 1999; Oh and Broyles, 2005; Slezak et al., 2004).  Immunocytochemical 
analyses of CHO and HeLa cells demonstrate YY1 is predominantly a cytoplasmic protein 
during G1- and G2-phases of the cell cycle and undergoes a DNA-replication dependent shift in 
localization to the nucleus during S-phase (Palko et al., 2004).  Accumulation of YY1 in the 
nucleus at the onset of S-phase appears to correspond to transcriptional regulation of replication-
dependent histone and other cell-cycle dependent genes by YY1 (Palko et al., 2004).  Krippner-
Heidenreich et al. also found YY1 to be predominantly cytoplasmic in HeLa cells, and found 
YY1 is rapidly translocated to the nucleus following application of apoptotic stimuli (Krippner-
Heidenreich et al., 2005).  YY1 has also been observed to be primarily cytoplasmic in quiescent 
(G0) 3T3 fibroblasts (Shestakova et al., 2004).  A study of expression and localization of YY1 in 
1364 prostate cancer tumour samples revealed statistically significant higher overall levels of 
YY1 expression and higher levels of cytoplasmic YY1 than in control tissues (Seligson et al., 
2005).  Decreased levels of nuclear YY1 and increased cytoplasmic abundance of the protein 
also correlated with decreased patient survival rates and higher (more severe) tumour 
morphological grading (Seligson et al., 2005).  Recently, Favot et al. studied YY1 cellular 
distribution in connexion with neonatal pulmonary hypertension in a newborn piglet model 
system (Favot et al., 2005).  It was found that YY1 was redistributed to the cytoplasm of vascular 
 14 
 
smooth muscle cells following hypoxia with a corresponding increase in expression of smooth 
muscle-specific markers and inhibition of cell proliferation (Favot et al., 2005).  Studies on 
chicken retinal cells show YY1 is highly expressed in photoreceptor cells and undergoes shifts in 
localization from nucleus to cytoplasm in response to light (Bernard and Voisin, 2008).  
Extensive studies of YY1 expression and subcellular localization have been undertaken in the 
brain of adult rats (Rylski et al., 2008).  Immunohistochemical analyses reveal YY1 is nuclear in 
most types of neural cells, but is present in the cytoplasm of stellate and basket cells of the 
molecular layer of the cerebellum which exhibit considerable plasticity (Rylski et al., 2008).  
Taken together, the literature suggests that redistribution of YY1 to the cytoplasm is a common 
mechanism used by cells to regulate its transcriptional activity.  None of these studies indicate a 
role for cytoplasmic YY1 beyond sequestering it from genomic DNA as a mechanism for 
controlling its transcriptional activity.  Given the drive toward efficiency implicit in evolution, it 
is not uncommon to discover multiple, sometimes unrelated, functions of a single protein.  
Studies directed at elucidating the role of YY1 in early development have suggested a non-
transcriptional role for cytoplasmic YY1 in development.      
The first studies of YY1 in development were carried out by Donohoe et al. who created 
YY1 knockout mice and established the essential role for YY1 in vertebrate development 
(Donohoe et al., 1999).  Homozygous YY1 knockout embryos implanted successfully in the 
uterine wall but failed to undergo gastrulation, indicating YY1 knockout results in embryonic 
death around the time of implantation (Donohoe et al., 1999).  Heterozygous embryos survived 
implantation but went on to display a number of defects such as lowered implantation efficiency, 
neurulation defects, and exencephaly (Donohoe et al., 1999).  Analysis of the nucleocytoplasmic 
distribution of YY1 in mouse development revealed it is entirely cytoplasmic in oocytes and in 
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zygotes until the 2-cell stage when transcription from the zygotic genome is activated (Donohoe 
et al., 1999).  YY1 was present in both nuclear and cytoplasmic compartments of cells of the 
blastocyst, inner cell mass, and trophoectoderm in stage E3.5 embryos (Donohoe et al., 1999).  
Whilst this study conclusively demonstrates a requirement for YY1 in mouse development, the 
researchers did not determine its transcriptional activity through development. 
Initial studies on YY1 in early development of Xenopus were performed by Ficzycz et al. 
with the aim of elucidating factors involved in histone gene expression in early development 
(Ficzycz et al., 1997).  Photocrosslinking experiments using late stage Xenopus embryo extracts 
revealed the presence of an 85 kDa polypeptide bound the H3.2 gene CRASα promoter region 
(Ficzycz et al., 1997).  This polypeptide was later identified as Xenopus YY1 (Ficzycz et al., 
2001).  Analysis of DNA-binding activity through development revealed that while YY1 protein 
levels remained relatively constant throughout development, YY1 DNA-binding activity was 
only present in early oocytes and post-MBT embryos (Ficzycz et al., 2001).  Subsequently, YY1 
transcriptional activity was investigated through development using reporter plasmid constructs 
microinjected in one-cell embryos (Ficzycz et al., 2001).  It was found YY1 did not significantly 
stimulate or repress transcription even in post-MBT embryos where YY1 DNA-binding activity 
had been demonstrated previously (Ficzycz et al., 2001).  This finding prompted analysis of the 
nucleocytoplasmic distribution of YY1 in oocytes and embryos.  YY1 was found to be entirely 
cytoplasmic from oocyte stage III, through fertilization and MBT, and into embryonic 
development until at least neurulation (stage 13) (Ficzycz et al., 2001).  Subcellular fractionation 
confirmed that YY1 was present only in the cytoplasm of neurula stage embryos (Ficzycz et al., 
2001). 
Knowledge of previously identified factors such as FRGY2A/B (Bouvet and Wolffe, 
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1994; Deschamps et al., 1992; Marello et al., 1992; Matsumoto et al., 1996; Matsumoto and 
Wolffe, 1998; Murray, 1994; Sommerville and Ladomery, 1996; Tafuri and Wolffe, 1993a; 
Yurkova and Murray, 1997) and CBTF (Brzostowski et al., 2000) known to play dual roles as 
transcription factors and as cytoplasmic RNA-binding proteins led to the theory that YY1 may be 
present in mRNP particles in the cytoplasm (Ficzycz et al., 2001).  The second zinc finger 
knuckle of YY1 is highly homologous with the RNA-binding zinc finger knuckles of the double 
stranded RNA binding protein TFIIIA, particularly in the spacing of key cysteine and histidine 
residues (Ficzycz and Ovsenek, 2002).  This homology suggested the possibility that YY1 
possesses an as-yet uncharacterized RNA-binding activity which could account for its 
association with maternal mRNA (Ficzycz and Ovsenek, 2002).  Furthermore, it was observed 
that treatment of cytoplasmic lysates from stage VI oocytes with RNase A resulted in acquisition 
of specific YY1 DNA-binding activity (Ficzycz and Ovsenek, 2002).  The presence of YY1 in 
mRNP particles was confirmed by oligo-dT cellulose chromatography of oocyte lysates, with 
retention of YY1 on oligo-dT cellulose matrix being abolished by treatment of lysates with 
RNase A (Ficzycz and Ovsenek, 2002).  Analysis of lysates by size exclusion chromatography 
demonstrated YY1 was present in complexes with an average apparent molecular mass of 480 
kDa and co-eluted with the known mRNP protein FRGY2A (Ficzycz and Ovsenek, 2002).  Size 
exclusion analysis also revealed that RNase treatment disrupted mRNPs and released YY1 
monomers (Ficzycz and Ovsenek, 2002).  Microinjection of RNase A directly into the cytoplasm 
was effective in disrupting mRNPs and unmasking YY1 DNA-binding activity but did not result 
in nuclear translocation of YY1, indicating nuclear exclusion of YY1 is not dependent on 
interaction with maternal mRNA (Ficzycz and Ovsenek, 2002).  Oligo-dT cellulose 
chromatography experiments using embryo lysates reveal that YY1 becomes associated with 
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mRNPs during oocyte stages III – IV, concomitant with accumulation of maternal mRNA, and 
persist in the embryo until neurulation, at which time YY1 appears as a monomer but remains 
restricted to the cytoplasm (Ficzycz et al., 2001; Ficzycz and Ovsenek, 2002; Ficzycz, 2003).  It 
is therefore likely that the nucleocytoplasmic redistribution of YY1 as a mechanism for 
regulating its transcriptional activity is distinct from its potential role in mRNPs. 
Several studies have subsequently looked at YY1 in Xenopus development.  Satijin et al. 
overexpressed YY1 in embryos and observed induction of an ectopic neural axis (Satijn et al., 
2001).  This work was published contemporaneously with the work of Ficzycz et al. and so there 
was no opportunity for Satijin et al. to consider potential YY1-RNA interactions in interpreting 
their results.  Ficzycz et al. have shown that YY1 is restricted to the cytoplasm at the time of 
neural axis formation using biochemical, immunohistochemical, and reporter-construct based 
approaches (Ficzycz et al., 2001; Ficzycz and Ovsenek, 2002; Ficzycz, 2003).  This is difficult to 
reconcile with the reports of transcriptional activity for YY1 made by Satijin et al. Given that 
Satijin et al. overexpressed both YY1 and its putative cofactor EED, did not analyze their 
subcellular location, and did not definitively demonstrate transcriptional activity of YY1 via 
reporter constructs, the precise relevance of this work to the in vivo situation is currently unclear 
(Satijn et al., 2001).  Kwon et al. used morpholino-modified antisense oligonucleotides to probe 
the function of YY1 in development (Kwon and Chung, 2003).  Microinjection of YY1-directed 
morpholinos (YY1-MO) resulted in anterior/posterior patterning defects and alterations in levels 
neural tissue specific markers (Kwon and Chung, 2003).  The results of morpholino experiments 
in Xenopus are notoriously difficult to interpret, with non-specific effects most often manifesting 
as defects in neurulation (Eisen and Smith, 2008; Heasman, 2002).  In the study by Kwon et al. 
the authors fail to convincingly show that microinjection of YY1-MO actually resulted in a 
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decrease in YY1 protein or an alteration in YY1 DNA-binding or transcriptional activity (Kwon 
and Chung, 2003).  While the authors localized high levels of protein to the neural crest and 
neural tube of the developing embryo, they did not determine its subcellular location (Kwon and 
Chung, 2003).  Again, the effects described by Kwon et al. seem to occur at a time when Ficzycz 
et al. describe an absence of YY1 transcriptional activity.  The work of Latinkic et al. constitutes 
the only other study of YY1 in Xenopus development (Latinkic et al., 2004).  Latinkic et al. 
convincingly demonstrated the involvement of YY1 transcriptional activity in regulation of the 
cardiac-specific MLC2 gene (Latinkic et al., 2004).  However, this activity takes place in 
embryonic stages well past neurulation, and beyond those analyzed by Ficzycz et al. at a 
developmental stage when YY1 is likely present in the nucleus (Latinkic et al., 2004).  At best, 
these studies taken together suggest a role for mRNP-associated YY1 in early Xenopus 
development; at worst, they certainly do not preclude such a role.  In either case, they certainly 
point to the need for further elucidation of the precise role of YY1 in embryogenesis prior to 
neurulation.  
     1.3  RIP-CHIP Analysis: Background and Overview – RNA 
immunoprecipitation/DNA microarray analysis (RIP-CHIP) is a methodology developed 
relatively recently for identifying the RNA present in RNA-protein complexes in a variety of 
experimental contexts (Baroni et al., 2008; Jain et al., 2010; Keene et al., 2006).  Essentially, the 
approach involves immunoprecipitation of a target RNA-binding protein, followed by isolation 
and labelling of the associated RNA.  This immunoprecipitated RNA can then be analyzed, and 
the RNAs present identified, by hybridization to an appropriate oligonucleotide DNA-
microarray.  RIP-CHIP has previously been used to identify microRNA targets in cancer cells, 
mammalian brain development, and during viral infection (Dolken et al., 2010; Nelson et al., 
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2010; Tan et al., 2009; Wang et al., 2010a; Wang et al., 2010b).  RIP-CHIP has been used to 
analyze the population of transcripts bound by the histone stem-loop binding protein (Townley-
Tilson et al., 2006), and to identify the RNA substrates of the chloroplast protein Whirly1 in 
barley (Melonek et al., 2010). Recently, RIP-CHIP has been applied in developmental biology to 
determine the turnover of mRNAs in muscle-cell precursors (Lee et al., 2010).  Lee et al. have 
used RIP-CHIP to identify dynamic association of mRNAs with the CUGBP1 protein in 
myoblasts (Lee et al., 2010).  Important findings included the identification of a subset of 
transcripts containing GU-rich sequences (termed GRE’s) rapidly degraded in myoblasts 
expressing CUGBP1 (Lee et al., 2010).  Included in this group of GRE containing transcripts 
were a number of transcripts encoding cell-cycle control proteins and intracellular transport, as 
well as MyoD1 and MyoG, encoding factors important in terminal differentiation of muscle 
tissue (Lee et al., 2010).  These observations led the authors to conclude that CUGBP1 mediates 
rapid decay of both transcripts required only transiently in the cell (i.e. those for cell-cycle 
control proteins) as well as transcripts for factors such as MyoD1 and MyoG that stimulate 
differentiation (Lee et al., 2010).   CUGBP1 was previously known to decline during myogenic 
differentiation.  The current data allowed the authors to hypothesize that decline of CUGBP1 
results in stabilization of MyoD1 and MyoG transcripts, whose protein products in turn drive 
myogenesis (Lee et al., 2010).  This hypothesis was then verified using antisense knockdown of 
CUGBP1, which resulted in accumulation of MyoD1 and MyoG transcripts (Lee et al., 2010).   
The foregoing example illustrates the utility of RIP-CHIP analysis in elucidation of the 
biological roles of RNA-binding proteins.  Lee et al. were able to use information obtained from 
RIP-CHIP analysis of substrates of CUGBP1, a protein known previously to decline specifically 
during differentiation of myoblasts, to directly determine the likely role of CUGBP1 in 
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myogenesis.  They were then able to directly test this hypothesis, resulting in significant insight 
into an important developmental process.  
RIP-CHIP analysis is an important, novel methodology for determining the RNA 
substrates of RNA binding proteins, particularly when there can be many thousands of substrate 
RNAs present, such as in mRNPs.  Here, RIP-CHIP is used to definitively identify in vivo 
substrates of the YY1 protein, providing insight into the putative biological role of YY1 in 
mRNPs.  RIP-CHIP relies on two pre-existing factors:  First, a DNA microarray for the organism 
in question must be available.  This has been achieved for Xenopus, particularly with the 
production of the Xenopus Genome 2.0 microarray by Affymetrix®.  Despite the term “Genome” 
in the title, the Xenopus Genome 2.0 array is not, in fact, a whole-genome array, as it does not 
include intergenic regions or introns.  This array includes 32,400 individual oligonucleotides 
(“spots”) representing approximately 29,900 Xenopus laevis transcripts and ESTs.  The second 
major requirement for useful RIP-CHIP experiments is adequate sequencing coverage for the 
model organism being used.  With Xenopus laevis this is somewhat lacking.  Sequencing of the 
X. laevis genome is still underway, and is complicated by the pseudotetraploidy of X. laevis, 
making alignment of sequenced genomic fragments extremely difficult (Bowes et al., 2010).  Of 
all transcripts and ESTs represented on the array, only about 20 % are annotated, constituting 
transcripts for named, characterized proteins.  A large part of the problem arises from the fact the 
X. laevis was one of the latest organisms to be used in high-throughput analyses such as 
genomics, transciptomics, and proteomics (Bowes et al., 2010).  It will undoubtedly take some 
time for all the Xenopus homologues of known mouse, human, and rat genes to be identified.  
Additionally, X. laevis sequences have not been annotated with Gene Ontology (GO) terms, and 
so high-throughput methods for determining common functional features for large sets of 
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mRNAs is also problematic (Bowes et al., 2010).  One way around this difficulty which is used 
in the current study was to retrieve the GO terms for the mouse homologue of each of the 
Xenopus transcripts; however this can only be applied to Xenopus transcripts whose protein 
products have been named and characterized.  Despite these difficulties, RIP-CHIP was able to 
identify 417 named and characterized transcripts associated with YY1, demonstrating the utility 
of the approach.  Furthermore, the dataset obtained can be used far into the future, to extract even 
more information as Xenopus laevis genomics and transcriptomics improve.  
1.4 Relevance and Objectives –The importance of mRNP complexes in development 
cannot be overstated given that all developmental processes occurring in the Xenopus embryo are 
governed by maternal mRNA stored mRNPs until activation of the zygotic genome at MBT 
(Davidson, 1986) and beyond (Bravo and Knowland, 1979).  Moreover, maternal mRNA 
continues to play a crucial role in later developmental events such as gastrulation, neurulation, 
and terminal differentiation of various cells and tissues (Bravo and Knowland, 1979; Davidson, 
1986).  Although the importance of mRNPs in vertebrate development has been known for 
almost 40 years (Ficq, 1970; Smith and Richter, 1985; Spirin, 1966), little is known about their 
structure or function.  The mechanisms by which specific mRNP proteins associate with maternal 
mRNA and the population of maternal mRNAs which associate with mRNPs and individual 
mRNP proteins is unknown.  One aim of the current study is to advance knowledge about the 
biochemistry and mRNA content of mRNPs, focussing on YY1 specifically.  The YY1 protein is 
a well-studied transcription factor which has subsequently been shown to be a component of 
oocyte mRNPs.  Rather than exhibiting a role in transcriptional regulation of early development, 
it would appear that YY1 has some biochemical activity in the cytoplasm.  This is evidenced by 
the studies described above which appear to show effects of YY1 on development during periods 
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when it has been shown to be sequestered in cytoplasmic mRNPs.  It is hypothesized based on 
structural analysis (Ficzycz and Ovsenek, 2002) that the YY1 protein possesses RNA-binding 
activity.  It is further postulated that RNA-binding activity underlies association of YY1 with 
maternal mRNA and with mRNPs in vivo.  Finally, a RIP-CHIP approach is employed to identify 
potential mRNA substrates of YY1 in mRNPs. It is hypothesized YY1 will not associate with 
transcripts from the mitochondrial genome or with mRNA undergoing active translation in the 
oocyte, consistent with previous data regarding the mRNA content of mRNPs (Braddock et al., 
1994; Smith and Richter, 1985; Woodland et al., 1979).   
The current study addresses these hypotheses as follows: The YY1 protein was 
bacterially expressed, and conditions for its efficient purification and renaturation were 
established.  In vitro analyses using recombinant YY1 revealed a high-affinity RNA binding 
activity, with a preference toward U-rich substrate RNA.  Subsequent experiments using 
endogenous YY1 isolated from oocytes confirm in vitro findings obtained with recombinant 
protein.  Microinjection of U-rich competitor RNA into oocytes selectively blocked association 
of YY1 with mRNPs, indicating RNA-binding activity is required for association with maternal 
mRNA in mRNPs in vivo.  In a novel application of the RIP-CHIP methodology, a specific 
antibody was used to immunoprecipitate YY1-mRNA complexes and isolated mRNAs were 
identified by DNA-microarray analysis.  This constitutes the most comprehensive analysis of the 
activity of any mRNP protein undertaken thus far, conclusively demonstrating that YY1 
associates with a subset of maternally transcribed mRNAs by direct RNA-binding activity.   
Furthermore, this is the first instance in which the actual, in vivo mRNA substrates of any of the 
known mRNP proteins have been identified.  Determination of the mRNA population present in 
YY1-mRNPs is a tremendous leap forward in understanding the role of YY1, maternal mRNA, 
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and mRNP complexes in control of early embryogenesis. 
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2.  Mater ials and Methods 
 
 2.1 General Procedures 
  2.1.1 Oocyte Manipulations, Microinjection, and Preparation of Lysates – All 
experiments involving animals were carried out according to The Guide for the Care and Use of 
Laboratory Animals and were approved by the Ethics Committee of the University of 
Saskatchewan.  Oocytes were isolated from the ovaries of adult female Xenopus laevis (Boreal) 
and maintained in OR2 buffer (82.5 mM NaCl, 2.5 mM KCl, 1 mM CaCl2, 1 mM MgCl2, 1 mM 
NaH2PO4, 5 mM HEPES (pH 7.6) at 18°C.  Stage VI oocytes were selected according to Dumont 
(Dumont, 1972).  Microinjections were performed using a Narashige® model IM-300 
microinjector.  For nuclear microinjection of DNA, 20 ng plasmid was injected in 20 nL of 0.1 M 
KCl at a pressure of 12 psi.  For cytoplasmic microinjections either 20 pg of RNase A or 5 pmol 
of the indicated RNA oligonucleotide were injected in 20 nL of 0.1 M KCl at 12 psi of pressure. 
Each injection needle was individually calibrated and at the indicated pressure injection rates 
were 0.1 nL/ms ± 20%.  Lysates were prepared by homogenizing 100 oocytes in 1 mL of mRNP 
buffer (150 mM NaCl, 50 mM Tris-HCl (pH 7.6), 2 mM MgCl2, 10% (v/v) glycerol, 1 mM DTT, 
1X Protease Inhibitor Cocktail (Sigma), 100 U/mL RNase inhibitor (Fermentas)), except that 
RNase inhibitor was omitted for experiments where lysates were treated with RNase A.  Lysates 
were centrifuged at 15,000 X g for 12 min at 4°C.  Supernatants were removed and centrifuged a 
second time and supernatants collected using care not to disturb the upper yolky layer.  Total 
oocyte RNA was isolated by homogenization of 100 oocytes in 1 mL Trizol® (Invitrogen) and 
processed according to the manufacturer’s directions.  
  2.1.2 Polymerase Chain Reaction – All PCR reactions were conducted under 
identical conditions.  Reactions contained 5.0 µL of 10X Taq Buffer (Fermentas), 2.5 mM 
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MgCl2, 250 nM forward and reverse primers, 250 µM dNTPs, 1.0 µL template DNA, and 5 U 
Taq DNA polymerase (Fermentas) in a final volume of 50 µL.  Reactions were cycled using an 
MJ Minicycler® using the following program: 95 °C/5 min; followed by 30 cycles of: 95 °C/45 
sec, 58 °C/45 sec, and 72 °C/2 min.  For PCR reactions with products less than 500 bp in length, 
the time of extensions were shortened to 1 min at 72 °C.  Fidelity and specificity of all primers 
was verified by electrophoresis of PCR reactions on TAE-agarose gels.  
  2.1.3 Western Blotting Procedures, Antibodies, and Silver Staining of SDS-
PAGE Gels – SDS-Polyacrylamide gel electrophoresis (SDS-PAGE) was carried out using 1 mm 
gels containing 10% (w/v) of 29:1 acrylamide:bisacrylamide according to standard protocols 
(Laemmli, 1970).  For Western transfer PVDF membranes (Bio-Rad) were pre-wet in methanol 
and equilibrated with transfer buffer (192 mM glycine, 25 mM Tris base, 10% (v/v) methanol).  
Transfers were carried out using a Bio-Rad semi-dry transfer apparatus at 25 V for 30 min at 
room temperature.  Membranes were blocked overnight in 5% milk/PBST (5 % (w/v) skim milk 
powder, 137 mM NaCl, 10 mM Na2HPO4, 2.7 mM KCl, 1.76 mM KH2PO4, 0.1% (v/v) Tween-
20, pH 7.4).  Primary antibodies were applied at the concentrations indicated for 2 h at room 
temperature in 5% milk/PBST.  Membranes were washed 3 X 30 min in 5% milk/PBST, then 
immersed in secondary antibody at the indicated concentration in 5% milk/PBST for 1 h at room 
temperature.  Finally, membranes were washed 2 X 10 min in 5% milk/PBST then 2 X 5 min in 
PBST.  Blots were treated with chemiluminescence reagent (PerkinElmer Life Sciences) for 1 
minute and exposed to BioMax MS Lite film (Kodak).  Antibodies used were:  Rabbit anti-YY1 
(Santa Cruz Biotechnology, Cat. #SC-281) at 1:1000; mouse anti-PCNA (Santa Cruz 
Biotechnology, Cat. #SC-56) at 1:5000; rabbit anti-His6 (Santa Cruz Biotechnology, Cat. #SC-
803) at 1:5000; mouse anti-HA (Santa Cruz Biotechnology, Cat. #SC-7392) at 1:5000; goat anti-
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rabbit HRP conjugate (Bio-Rad, Cat. #170-6515) at 1:3500; and goat anti-mouse HRP conjugate 
(Bio-Rad, Cat. #170-6516) at 1:5000.   
Gels were silver stained using the Bio-Rad silver stain kit (Cat. #161-0443) according to 
the manufacturer’s directions.  Gels were stained with coomassie blue by immersion overnight in 
a solution containing 0.5% (w/v) coomassie brilliant blue R250, 40% (v/v) methanol, and 10% 
(v/v) glacial acetic acid.  Gels were destained in 40% (v/v) methanol/10% (v/v) glacial acetic 
acid and rehydrated in distilled water.  
  2.1.4 Immunoprecipitations – Immunoprecipitation of YY1 was carried out 
using a custom-made polyclonal antibody (OpenBiosystems) raised in rabbit against a synthetic 
peptide with sequence AMRKHLHTHGPRVH corresponding to amino acids 268-281 of 
Xenopus laevis YY1 (Accession NP_001087404).  Oocyte lysates were prepared in mRNP lysis 
buffer as described in section 2.1.1.  All solutions and buffers used were freed of RNase by 
treatment with DEPC.  Protein-A agarose beads (Sigma) were swollen overnight in five volumes 
NT2 buffer (150 mM NaCl, 50 mM Tris-HCl (pH 7.5), 1 mM MgCl2, 0.05% (v/v) Nonidet P-40) 
supplemented with 5% (w/v) BSA.  Swollen beads were washed twice in five volumes of 
NT2+BSA.  Antibody conjugation reactions were assembled by addition of 50 µL (10 µg) 
antibody to 150 µL pre-swollen protein-A agarose beads in a volume of 1 mL NT2+BSA and 
incubation overnight at 4 °C.  Antibody conjugated beads were washed six times with 1 mL 
NT2+BSA and used immediately in immunoprecipitation reactions.  Lysate (1 mL) was added to 
antibody conjugated beads and incubated with gentle agitation for 2 h at room temperature.  
Beads were washed six times with 1 mL NT2 (without BSA) and resuspended in 200 µL 1X 
SDS-PAGE loading buffer or used for extraction of mRNA as described in section 2.4.1 below. 
  2.1.5 Isolation of oocyte Poly-A+ RNA – Total oocyte RNA was isolated using 
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Trizol® extraction according to the manufacturer’s direction as outlined in section 2.1.1.  
Isolation of poly-A+ RNA was performed in accordance with Sambrook and Russell (Sambrook, 
2001).  Type VII Oligo-dT cellulose (New England Biolabs) (0.5 g) was suspended in 0.1 N 
NaOH and poured into disposable chromatography columns.  Matrices were then washed 
extensively with nuclease-free water and then with 1X column loading buffer (500 mM NaCl, 20 
mM Tris-HCl (pH 7.6), 1 mM EDTA, 0.1% (w/v) SDS).  Samples of total RNA from 100 
oocytes were suspended in 500 µL of nuclease-free water and heated at 70 °C for 5 minutes, 
chilled on ice, then mixed with 500 µL of 2X column loading buffer (1 M NaCl, 40 mM Tris-
HCl (pH 7.6), 2 mM EDTA, 0.2% (w/v) SDS).  The RNA solutions were applied to oligo-dT 
cellulose columns and the flow-through aliquots were collected, reheated at 70 °C, chilled, and 
reapplied to the column.  Columns were then washed with 5 mL of 1X column loading buffer.  
Poly-A+ RNA was eluted by applying 2.5 mL of elution buffer (10 mM Tris-HCl (pH 7.6), 1 
mM EDTA, 0.05% (w/v) SDS) and collecting 200 µL fractions.  The OD260 of the resulting 
fractions was measured and fractions containing RNA were pooled.   Pooled fractions were 
supplemented with 1/10 volume 3 M sodium acetate (pH 5.2) and RNA precipitated by addition 
of 2.5 volumes absolute ethanol followed by centrifugation at 15,000 X g for 15 min at 4 °C.  
Pellets were washed once with ice-cold 75% (v/v) ethanol and resulting poly-A+ RNA fractions 
were resuspended in 100 µL nuclease-free water and quantified by UV spectrophotometry.  
Samples with OD260/OD280 ratio of > 1.8 were utilized.   
  2.1.6 Size Exclusion Chromatography – Oocytes were lysed in mRNP buffer as 
described in section 2.1.1.  Lysates were extracted once with an equal volume of 1,1,2-
trichlorotriflouroethane to remove yolk proteins prior to chromatography.  Lysates (300 µL) were 
applied to a 0.75 cm X 5 cm columns of G-200 Sephadex resin (Amersham) pre-equilibrated in a 
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buffer containing 150 mM NaCl, 50 mM Tris-HCl (pH 7.6), 2 mM MgCl2, 1 mM DTT.  
Fractions (500 µL) were collected and protein/RNA content estimated by UV spectroscopy at 
260 nm and 280 nm.  Fractions were precipitated by addition of four volumes of acetone 
followed by centrifugation at 20,000 X g for 20 min at 4 °C.  Pellets were washed once with 1 
mL ice-cold 80% acetone, dried, and resuspended in 50 µL 1X SDS-PAGE loading buffer 
containing 8 M urea.  Columns were calibrated using Bio-Rad size exclusion molecular mass 
standard (Cat. #151-1901).  
2.2 Expression and Pur ification of Recombinant Xenopus laevis YY1 
  2.2.1 Construction of pHA3-YY1 and pRsetB-YY1 – Plasmid isolation, 
transformation, DNA purification, restriction endonuclease digestion, and ligations were 
performed according to the protocols described by Sambrook and Russell (Sambrook, 2001), and 
all enzymes used were purchased from Fermentas.   
The pHA3-YY1 plasmid used for expression of HA-YY1 in oocytes contains the 
Xenopus YY1 coding sequence fused to an N-terminal HA-tag under control of CMV promoter 
and was constructed as follows:  PCR amplification was used to generate a fragment containing 
the Xenopus YY1 coding sequence from oocyte cDNA using a forward primer incorporating an 
BglII restriction site (5’-CGCGAGATCTATGAACATGGCATCGGGC) and a reverse primer 
incorporating a HpaI restriction site (5’-ATATGGAAAGACATGTTATCCCAATTGGCGC).  
The PCR product was digested with BglII/HpaI and purified by electrophoresis through low 
melting point agarose.  The digested fragment was ligated in-frame into BglII/HpaI digested, 
phosphatase-treated pHA3 plasmid and subsequently transformed into E. coli DH5α cells.  The 
sequence of Xenopus YY1 was confirmed by sequencing at the Plant Biotechnology Institute, 
University of Saskatchewan.  
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pRsetBYY1, used for in vitro expression, contains the YY1 sequence fused to an N-
terminal 6XHis tag under control of the bacteriophage T7 promoter and was constructed by sub-
cloning of the YY1 coding sequence from pHA3-YY1 as follows:  pHA3-YY1 was digested 
with BglII/HpaI and the liberated fragment containing the YY1 coding sequence was isolated by 
electrophoresis of the endonuclease-digestion reaction through low melting point agarose.  This 
fragment was ligated in-frame into BglII/PvuII digested, phosphatase-treated pRsetB plasmid 
generating pRsetB-YY1.  Initially, pRsetB-YY1 was maintained in E. coli DH5α.   For 
expression of the YY1 protein, the pRsetB-YY1 vector was purified from cultures of DH5α cells 
and transformed into E. coli BL21(DE3) pLysS, generating the BL21(DE3) pLysS pRsetBYY1 
strain. 
  2.2.2 Expression and Lysis – Expression of recombinant YY1 was achieved as 
follows: BL21(DE3) pLysS pRsetB-YY1 cells were inoculated into 3 mL aliquots of LB media 
(Sambrook, 2001) containing antibiotics (50 µg/mL ampicillin (Sigma) and 35 µg/mL 
chloroamphenicol (Sigma)) and incubated at 37 °C for 24 h.  These cultures were then used to 
inoculate a subsequent 50 mL cultures also containing antibiotics, followed by incubation for 24 
h at 37 °C.  The 50 mL cultures were then used to inoculate 1 L of SOB medium (Sambrook, 
2001) preheated to 37 °C.  Incubation at 37 °C was continued until the OD600 of the culture 
reached 0.6 at which point it was supplemented with 2 mM IPTG and incubation continued for 
an additional 4 h to allow for expression of recombinant protein.  Cultures were then chilled for 
20 min on ice and centrifuged at 5,000 X g for 10 min at 4 °C to pellet the bacterial cells.  Cells 
were washed once with 200 mL ice-cold STE (100 mM NaCl, 10 mM Tris-HCl (pH 7.6), 1 mM 
EDTA) and collected by centrifugation at 5,000 X g for 10 min at 4 °C.  Pelleted cells were lysed 
in 20 mL of Lysis Buffer A (8 M urea, 50 mM NaH2PO4/Na2HPO4 (pH 8.0), 1 % (w/v) SDS, 2 
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mM 2-mercaptoethanol) with vigorous shaking for 30 min, then cell lysates were sonicated 2 X 
30 sec on setting five of a Sonifier® model W140 sonicator (Heat Systems-Ultrasonics Inc; 
Plainview, NY).  Lysates were then diluted with 20 mL of Lysis Buffer B (600 mM NaCl, 50 
mM NaH2PO4/Na2HPO4 (pH 8.0), 20 mM imidazole (pH 8.0)) and mixed thoroughly.  Lysates 
were clarified by centrifugation at 40,000 X g for 30 min at 4 °C and stored at -80 °C. 
 For evaluation of different lysis buffers, equal quantities of cells suspended in STE were 
centrifuged (5000 X g, 5 min, 4 °C) and pellets resuspended either directly in 250 µL 1 X SDS-
PAGE loading buffer (50 mM Tris-HCl (pH 6.8), 2 % (w/v) SDS, 100 mM 2-mercaptoethanol, 
10 % (v/v) glycerol, 0.1 % (w/v) bromophenol blue) containing 8 M urea, or 5 mL of one of the 
following four lysis buffers: Lysis Buffer I (300 mM NaCl, 50 mM NaH2PO4/Na2HPO4 (pH 8.0), 
1 X protease inhibitor cocktail (Sigma)), Lysis Buffer II (300 mM NaCl, 50 mM 
NaH2PO4/Na2HPO4 (pH 8.0), 1 X protease inhibitor cocktail (Sigma), 1 mg/mL lysozyme), Lysis 
Buffer III (6 M guanidium hydrochloride, 50 mM NaH2PO4/Na2HPO4 (pH 8.0)), or Lysis Buffer 
IV (8 M urea, 50 mM NaH2PO4/Na2HPO4 (pH 8.0), 1 % (w/v) SDS).  Samples were placed on a 
centrifugal shaker at medium speed for 30 min then sonicated 2 X 30 sec on setting five of a 
Sonifier® model W140 sonicator (Heat Systems-Ultrasonics Inc; Plainview, NY).  Samples were 
then centrifuged (40,000 X g, 30 min), and pellets resuspended in 250 µL of 1 X SDS-PAGE 
loading buffer containing 8 M urea. Proteins were recovered from supernatants by addition of 20 
mL ice-cold ethanol and centrifuged (40,000 X g, 30 min, 4 °C) to collect precipitated protein 
and resulting pellets then also resuspended in 250 µL 1 X SDS-PAGE loading buffer containing 
8 M urea. 
 Lysates for analysis of protein stability were prepared by resuspending the pelleted cells 
from 1 L cultures of IPTG-induced BL21(DE3) pLysS pRsetBYY1 in either 20 mL Lysis Buffer 
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IV, Lysis Buffer IV containing 1 mM 2-mercaptoethanol, or in Lysis Buffer IV containing 1 mM 
hydrogen peroxide.  Suspensions were shaken at room temperature for 30 min, sonicated as 
above, and then diluted with 20 mL Lysis Buffer B (600 mM NaCl, 50 mM NaH2PO4/Na2HPO4 
(pH 8.0), 20 mM imidazole (pH 8.0)), centrifuged (40,000 X g, 30 min, 4 °C), and supernatants 
incubated at either room temperature or 37 °C.  At the indicated time points, 100 µL aliquots 
were removed and mixed with 25 µL of 5 X SDS-PAGE loading buffer lacking 2-
mercaptoethanol, heated at 95 °C for 5 min, and analyzed by Western blotting. 
  2.2.3 Immobilized Metal Affinity Chromatography – Recombinant YY1 with 
the N-terminal 6XHis tag was purified using immobilized metal affinity chromatography 
(IMAC) on nickel-charged NTA-agarose (BioRad) columns.  All chromatography steps were 
performed on a BioRad HR control unit (BioRad) at room temperature using 2 cm diameter 
columns with a packed volume of 10 mL resin.  Prior to application of bacterial lysates, the 
IMAC columns were equilibrated with 50 mL Wash Buffer (300 mM NaCl, 50 mM 
NaH2PO4/Na2HPO4 (pH 8.0), 20 mM imidazole (pH 8.0), 1 mM 2-mercaptoethanol).  Bacterial 
lysates containing recombinant YY1 (40 mL) were applied to the columns by recirculation for 16 
h.  Matrix was then washed with 100 mL Wash Buffer and bound protein was recovered into 5 
mL fractions with 50 mL Elution Buffer (300 mM NaCl, 50 mM NaH2PO4/Na2HPO4 (pH 8.0), 
200 mM imidazole (pH 8.0), 1 mM 2-mercaptoethanol).  Fraction aliquots (100 µL) were 
analyzed by SDS-PAGE followed by Western blotting and Coomassie Blue staining (see 5.1.3).  
Fractions containing recombinant protein were assayed for protein content by the method of 
Bradford (Bradford, 1976), pooled, and stored at -80 °C. 
 Automation of column recharging procedures improved efficiency and consistency of the 
entire IMAC process.  Columns were regenerated between uses by stripping of nickel ions from 
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the column with EDTA followed by acid washing, resulting in complete removal of any residual 
proteins from the column (Belew et al., 1987).  Following elution of bound proteins, columns 
were regenerated as follows: Nickel ion stripping with 50 mL of 0.1 M EDTA (pH 8.0), followed 
by sequential washing with 100 mL water, 100 mL Acid Wash Solution (0.12 M H3PO4,  2 % 
(v/v) glacial acetic acid (pH ~2.0)), and a further 100 mL water.  Columns were recharged with 
nickel ions by equilibration with 50 mL of 50 mM sodium acetate (pH 6.2), then subsequently 
with 50 mL of Nickel Solution (0.25 M NiSO4, 25 mM sodium acetate (pH 6.2)), followed by a 
second equilibration with 50 mL of 50 mM sodium acetate (pH 6.2), and a final wash with 100 
mL water.  Columns were prepared for subsequent chromatography by equilibration with 50 mL 
Wash Buffer.   
  2.2.4 Renaturation – Renaturation of recombinant YY1 was carried out by spin 
dialysis using a Macrosep® 10K Omega (Pall Life Science) centrifugal device at 5,000 X g and 
4 °C.  Pooled fractions of eluted protein (see 5.2.3 above) were supplemented with guanidium 
isothiocyanate to a final concentration of 6 M and 0.5 M EDTA to a final concentration of 25 
mM. Samples were concentrated by spin dialysis to 500 ng/µL of protein. Each step in the 
renaturation process was performed by two-fold diluting of preparations with Renaturation 
Buffer and then re-concentrating, as indicated, to 500 ng/µL.  Addition of 25 mM EDTA was 
required to remove residual nickel ions which were found to inhibit DNA and RNA binding 
activity of YY1.  Protein was exchanged via ten cycles of dilution and re-concentration into a 
Renaturation Buffer containing 150 mM KCl, 50 mM Tris-HCl (pH 7.5), 2 mM MgCl2, 0.2 mM 
ZnCl2, 1 mM 2-mercaptoethanol, and 10% (v/v) glycerol.  Following renaturation, recombinant 
YY1 was concentrated to 860 ng/µL (20 µM) and stored frozen at -80 °C until use.  Samples 
containing different concentrations of YY1 were prepared by dilution of 20 µM stock in the 
 33 
 
renaturation buffer described above.  For some experiments, YY1 was exchanged into 
renaturation buffer lacking zinc and magnesium ions and instead containing 0.1 mM EDTA. 
 2.3 Analysis of YY1 nucleic acid binding activity 
  2.3.1 Radiolabelling and pur ification of DNA and RNA probes – 
Oligonucleotide probes (See Table 1) were radiolabelled and purified as follows in accordance 
with the protocols of Sambrook and Russell (Sambrook, 2001).  Double-stranded DNA probes 
were end-fill labelled using [α-32P]dCTP (PerkinElmer Life Sciences) and MLuV reverse 
transcriptase (Fermentas).  Single-stranded DNA and RNA probes were end-labelled using [γ-32P 
]ATP (PerkinElmer Life Sciences) and T4 polynucleotide kinase (Fermentas).  Double-stranded 
RNA probes were prepared by labelling reciprocal strands and then purified and annealed to the 
complimentary unlabelled strand.  Double-stranded RNA probe integrity was further verified by 
treatment of aliquots with single-strand specific ribonuclease (data not shown).  GAPDH 3’UTR 
and β-Globin 3’UTR probes were prepared by in vitro transcription of PCR products prepared as 
in section 2.1.2 using gene-specific primers (see Table 1) incorporating a 5’ T7 promoter 
sequence. The Xenopus 5S rRNA was synthesized from the T7 promoter of linearized 
pUC19wt5S (a kind gift of P.J. Romaniuk, University of Victoria).  In vitro transcription 
reactions were performed using T7 polymerase (Fermentas) and [α-32P]UTP (PerkinElmer Life 
Sciences) by the method of Kreig and Melton (Krieg and Melton, 1984) with inclusion of 
7mGpppG cap analogue (Invitrogen) in reactions generating capped transcripts.  Labelled probes 
were diluted with 100 µL RNase-free TEN (100 mM NaCl, 20 mM Tris-HCl (pH 7.6), 2 mM 
EDTA) and purified by passing over 500 µL G-50 Sephadex 
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(Amersham) previously equilibrated in TEN.  The resulting solution was extracted with 
phenol/chloroform (1:1), then chloroform/isoamyl alcohol (19:1), and precipitated by addition of 
1/3 volume 7.5 M ammonium acetate and 2.5 volumes of ethanol.  Oligonucleotides were 
collected by centrifugation at 20,000 X g for 20 min at 4 °C and pellets washed once with 1 mL 
ice-cold 75% ethanol.  The state of purity was monitored by electrophoresis on 20% 
polyacrylamide, 0.5X TBE gels containing 8.3 M urea.  Once no trace of unincorporated label 
could be detected by 12 h of radiography using Kodak XB-1 film (Kodak), oligonucleotides 
were quantified by UV spectroscopy in a Bio-Rad Smartspec® (BioRad) using millimolar 
extinction coefficients specific to the oligonucleotide being measured.  Only samples with an 
OD260/OD280 ratio greater than 1.8 were used. 
  2.3.2 YY1/DNA and YY1/RNA Electrophoretic Mobility Shift Assays – Unless 
otherwise specified, DNA and RNA binding reactions contained 0.1 pmol radiolabelled 
oligonucleotide, 50 mM NaCl, 50 mM Tris-HCl (pH 7.5), 2 mM MgCl2, 1 mM DTT, and the 
indicated quantity of protein in a final volume of 10 µL.  Reactions containing oocyte lysate, 
cellular lysate, or purified mRNPs, contained a final volume of 20 µL. Reactions containing 
RNA probes were supplemented with 10 U/µL of RNase inhibitor (Fermentas).  For competition 
experiments, oligonucleotides (1 pmol) or antibodies (200 ng) were added directly to binding 
reactions.  Reactions were incubated at room temperature (unless specified otherwise) for 20 
min, mixed with 2 µL loading dye (0.1% (w/v) bromophenol blue, 0.1% (w/v) xylene cyanol FF, 
50% (v/v) glycerol) and immediately loaded onto non-denaturing 5% polyacrylamide gels 
containing 0.5 X TBE buffer (Sambrook, 2001).  Gels were run at 150 V for 2.5 h at 4 °C, then 
dried and exposed for 16 h to XB-1 film (Kodak) at -80 °C with an intensifying screen. 
  2.3.3 Nitrocellulose Filter Binding Assays – Nitrocellulose filter binding assays 
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were performed according to Romaniuk (Romaniuk, 1985) with slight modifications.  Binding 
reactions were carried out by addition of various concentrations of recombinant YY1 to 0.5 pmol 
radiolabelled probe in a final volume of 50 µL of Binding Buffer (50 mM NaCl, 50 mM Tris-
HCl (pH 7.5), 2 mM MgCl2 and 1 mM DTT).  For binding reactions using RNA probes, binding 
reactions were supplemented with 50 U RNase-inhibitor (Fermentas).  After 20 min at room 
temperature, reactions were diluted with 50 µL Binding Buffer and immediately applied to pre-
equilibrated 0.45 µm nitrocellulose membranes (Bio-Rad) contained in a Bio-Rad dot-blot 
apparatus.  Filters were washed twice with 100 µL binding buffer and then dried for 90 min at 80 
°C in vacuo.  Filters were dissolved in 500 µL benzethonium hydroxide (Alfa Asar) in methanol 
then mixed with 15 mL of scintillation fluid.  Radioactivity was measured in a Tri-Carb 3100TR 
scintillation counter (Packard Biosciences, Meriden, CT).  Background readings were subtracted 
from all data values and Kd values were calculated using the MatLab® software package.  
Presented data is the average of three replicate experiments.  
  2.3.4 Determination of YY1 minimal binding site – U20 RNA was partially 
nuclease-digested by combining 5 pmol end-labelled (see section 2.3.1) U20 RNA with 1 ng 
RNase A (Fermentas) in 50 µL of RNase-free TMN (100 mM NaCl, 20 mM Tris-HCl (pH 7.6), 2 
mM MgCl2) followed by incubation at room temperature for 20 minutes.  Reactions were 
quenched by addition of 0.5 M EDTA (pH 8.0) to a final concentration of 5 mM, and then 
extracted twice with 1:1 (v/v) phenol/chloroform and then once with 19:1 (v/v) 
chloroform/isoamyl alcohol.  The aqueous phase was then supplemented with 25 µL 7.5 M 
ammonium acetate and 10 µg RNA-grade glycogen (Fermentas) and the RNA precipitated by 
addition of 2.5 volumes absolute ethanol.  After chilling on ice (10 min) the precipitated RNA 
samples were collected by centrifugation (20,000 x g, 20 min, 4 °C) and washed once with 250 
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µL of ice-cold 80% (v/v) ethanol.  The dry pellet was used immediately in YY1 RNA-binding 
reactions.  
 RNA binding reactions were assembled by resuspension of digested RNA probe in 200 
µL RNA-binding buffer (50 mM NaCl, 50 mM NaH2PO4/Na2HPO4 (pH 7.5),  2 mM MgCl2, 0.5 
mM 2-mercaptoethanol, and 0.1 U/µL RNase-inhibitor (Fermentas)) and adding 0.2 nmol 
recombinant YY1.  Control reactions were identical except no recombinant YY1 was added.  
Binding reactions were incubated at room temperature for 20 min and then transferred to a fresh 
tubes containing 50 µL nickel-charged NTA-agarose resin (BioRad) pre-equilibrated with 
binding buffer.  Reactions were incubated a further 20 min at room temperature with gentle 
rotation.  NTA-agarose beads were collected by centrifugation (1000 x g, 1 min) and washed 
with 3 X 1 mL RNA-binding buffer.  Washed beads were resuspended in 50 µL formamide 
loading buffer (80% (v/v) formamide, 100 mM Tris-HCl (pH 8.0), 0.05 % (w/v) bromophenol 
blue, 0.05% (w/v) xylene cyanol FF) and heated at 95 °C for 5 min then chilled on ice.  NTA-
agarose beads were removed by centrifugation (12,000 x g, 10 min) and supernatants analyzed 
immediately by denaturing polyacrylamide gel electrophoresis. 
 For resolution of small RNA fragments a special high-strength acrylamide gel solution 
containing a 20 % (w/w) acrylamide, 12:1 acrylamide:bisacrylamide ratio was prepared as 
follows:  49.8 g urea (8.3 M final concentration, Sigma), 18.4 g acrylamide (Sigma), 1.6 g 
bisacrylamide (Sigma), and 10 mL 5 X TBE Buffer (0.22 M Tris Base, 0.22 M Boric Acid, 5 mM 
EDTA) were dissolved in water to a final volume of 100 mL.  Gel solutions were stored at room 
temperature and used within 2 - 3 weeks of preparation.  To prepare gels, 25 mL of the above 
acrylamide solution was mixed with 250 µL of 10% (w/v) ammonium persulfate and 10 µL of 
N,N,N',N'-tetramethyl-ethane-1,2-diamine (TEMED) and poured at a thickness of 0.75 mm.  All 
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electrophoresis steps were performed using 0.5 X TBE as the tank buffer.  Prior to loading of 
samples, gels were pre-run at 200 V for 20 min.  Analysis of RNA-binding reactions was 
performed by loading approximately 20 cps of RNase-digested RNA probe (as marker) and 5 µL 
of formamide eluant obtained from RNA-binding reactions described above into the adjacent 
lanes.  Electrophoresis was conducted at 200 V for approximately 1.5 hours, until the 
bromophenol blue fronts had migrated approximately 2/3 of the distance to the bottom of the gel.  
Following electrophoresis, gels were removed, covered with plastic wrap, and exposed to Kodak 
XB-1 radiography film with an intensifying screen at -80 °C for periods varying from 12 h to 10 
days.  
  2.3.5 Oligo-dT Cellulose Chromatography and Pur ification of YY1 from 
Oocyte mRNPs – For preparation of oocyte mRNPs by oligo-dT cellulose chromatography, 
lysates prepared as in section 2.1.1 were extracted with an equal volume of 1,1,2-
trichlorotrioflouroethane to remove yolk proteins and supplemented with additional sodium 
chloride to a final concentration of 300 mM NaCl. Cleared lysate (1 mL) was applied to 100 mg 
of pre-equilibrated type VII Oligo-dT cellulose (New England Biolabs) and incubated with 
gentle agitation for 2 h at 4 °C.  Following incubation matrix mixtures were washed twice with 
five volumes ice-cold Binding Buffer (300 mM NaCl, 50 mM Tris-HCl (pH 7.5), 2 mM MgCl2, 
1 mM DTT).  For isolation of native mRNPs, mixtures were batch-eluted twice with 2 mL of 
Elution Buffer (300 mM NaCl, 50 mM Tris-HCl (pH 7.5), 5 mM EDTA, 30% (v/v) de-ionized 
formamide).  Eluted mRNPs were exchanged into Renaturation Buffer (50 mM KCl, 50 mM 
Tris-HCl (pH 7.5), 2 mM MgCl2, 0.2 mM ZnCl2, 1 mM DTT) and concentrated to a volume of 
0.5 mL by spin-dialysis using a Microsep 10K omega centrifugal device (Pall Corporation) 
yielding approximately one oocyte equivalent of mRNPs per 10 µL.  For analysis of HA-YY1 
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expressing oocytes, matrix mixtures were eluted directly in 200 µL of 1X SDS-PAGE loading 
buffer.  For analysis of recombinant YY1, binding reactions were carried out in the presence of 
100 mg of oligo-dT cellulose, 0.5 µg of poly-A+ oocyte RNA (see section 2.1.5) and 10 pmol of 
rYY1 and either 1 µg RNase A (Fermentas) or 20 pmol of U20 or C20 as indicated. 
 Analysis of the stability of mRNP-associated YY1 with respect to ionic perturbation was 
conducted using oligo-dT cellulose chromatography as follows:  lysates were freed of yolk 
proteins by extraction of 1,1,2-trichlorotriflouroethane as described above.  Columns were 
maintained at 4 °C and run at a flow-rate of 0.1 mL/min using a BioLogic HR control unit 
(BioRad).  Lysates (1 mL) were applied to type VII oligo-dT cellulose (New England Biolabs) 
columns with a bed volume of 2 mL after pre-equilibration in Binding Buffer (150 mM NaCl, 50 
mM Tris-HCl (pH 7.5), 2 mM MgCl2, 1 mM DTT).  Bound proteins were eluted in 200 µL 
fractions with the above binding buffer containing a range of NaCl concentrations from 100 mM 
to 2 M.  Proteins were precipitated by adding 4 volumes of ice-cold acetone and pelleted by 
centrifugation at 20,000 X g for 20 min at 4 °C.  Precipitated proteins were resuspended in 50 µL 
1X SDS-PAGE loading buffer and analyzed by Western blotting as described in section 2.1.3. 
 2.4 Immunoprecipitation and  Identification of YY1-associated mRNA by DNA 
Microarray 
  2.4.1 Isolation of Immunoprecipitated mRNA - Following immunoprecipitation 
with anti-YY1 antibody as described above (see 2.1.4), protein-A agarose beads were suspended 
in 1 mL Trizol(R) (Invitrogen) reagent.  RNA was isolated from immunoprecipitated material as 
follows: samples suspended in Trizol were supplemented with 200 µL of chloroform and 
vortexed vigorously then centrifuged at 12,000 x g for 10 min at 4 °C.  Supernatants were 
collected and extracted with 600 µL of 19:1 (v/v) chloroform/isoamyl alcohol and centrifuged 
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(12,000 X g, 5 min, 4 °C).  Supernatants were collected and RNA precipitated by the addition of 
10 µg RNase-free glycogen (Fermentas) as carrier and 500 µL isopropanol.  After chilling on ice 
(10 min) RNA was collected by centrifugation at 20,000 x g for 20 min at 4 °C.  Pellets were 
rinsed once with 1 mL 75% (v/v) ethanol.  After allowing excess ethanol to evaporate, RNA 
samples were resuspended in 50 µL RNase-free water and RNA quality was determined non-
destructively by UV spectroscopy in sterile, RNase-free methacrylate cuvettes (BioRad).  
Following spectroscopic analysis, 5.5 µL of 3 M Sodium Acetate (pH 5.2) and 140 µL absolute 
ethanol were added and RNA samples were stored as the ethanol precipitate at -20 °C until use. 
  2.4.2 First-cycle Reverse Transcr iption - RNA samples stored as the ethanol 
precipitates were centrifuged (20,000 x g, 20 min, 4 °C) and pellets dried briefly to remove 
excess ethanol.  The dried pellets were then resuspended in 3.0 µL RNase-free water then mixed 
with 1.0 µL “poly-A spike-in control RNA” (Affymetrix) and 1.0 µL of 5 uM Oligo-dT/T7 
primer were added (“poly-A spike-in control RNA” contains a mixture of bacterially derived 
transcripts at known concentrations, these transcripts are used to normalize signal intensity 
values during reading of the microarray).  Mixtures were heated at 70 °C for 10 min and then 
chilled on ice for 5 min.  Reverse transcription reactions were assembled by addition of 2.0 µL 
5X First Strand Buffer (Invitrogen), 1.0 µL of 0.1 M DTT, 0.5 µL (20 U) of RNase-inhibitor 
(Fermentas), 0.5 µL of 10 mM dNTPs, and 1.0 µL of SuperScript Reverse Transcriptase 
(Invitrogen).  Reactions were incubated at 42 °C for 1 h then heated at 70 °C for 10 min to 
inactivate Reverse Transcriptase, then chilled on ice.  Second-strand synthesis reactions were 
assembled by addition of the following to the chilled first-strand reaction (10 µL): 4.8 µL RNase-
free water, 4.0 µL of 17.5 mM MgCl2, 0.4 µL of 10 mM dNTP mix, 0.6 µL E. coli DNA 
polymerase I (Invitrogen) and 0.2 µL RNase H (Invitrogen).  Reactions were incubated at 16 °C 
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for 2 hours then heated to 75 °C for 10 min and chilled on ice. 
  2.4.3 In Vitro Transcr iption - The double-stranded cDNA solutions obtained 
above were used directly in in vitro transcription reactions using the Ambion MegaScript T7 in 
vitro transcription kit (Ambion) components with modification of the supplier's protocol as 
follows:  To  cDNA solutions (20 µL) were supplemented with 5.0 µL 10X IVT buffer, 5.0 µL 75 
mM ATP, 5.0 µL 75 mM GTP, 5.0 µL 75 mM CTP, 5.0 µL 75 mM UTP, and 5.0 µL T7 RNA 
Polymerase giving a final volume of 50 µL.  Reactions were incubated at 37 °C for 16 h then 
chilled on ice.  In vitro transcribed RNA (cRNA) was purified and separated from template DNA 
via the Affymetrix cRNA cleanup kit (Affymetrix) according to the manufacturer's direction.  
The purified cRNA was used immediately in second-cycle cDNA synthesis as described below. 
  2.4.4 Second-cycle Reverse Transcr iption – The cRNA solutions obtained above 
in a volume of 9.0 µL were mixed 2.0 µL of 200 ng/µL random primers (Invitrogen), heated at 
70 °C for 10 min, chilled on ice (5 min) and mixed with: 4.0 µL 5X First Strand Buffer 
(Invitrogen), 2.0 µL 0.1 M DTT, 1.0 µL (40 U) RNase-inhibitor (Fermentas), 1.0 µL of 10 mM 
dNTP mix, and 1.0 µL SuperScript Reverse Transcriptase (Invitrogen) for a final volume of 20 
µL.  Reactions were incubated at 42 °C for 1 h, chilled briefly on ice, supplemented with 1.0 µL 
RNase H (Invitrogen), and incubated a further 20 min at 37 °C.  The reaction was then heated at 
95 °C for 5 min to inactivate enzymes and chilled on ice.  Second strand reactions were 
assembled by addition of 4.0 µL of 5 µM Oligo-dT/T7 primer followed by heating at 70 °C for 
10 min, chilling on ice (5 min), and addition of 88 µL RNase-free water, 30 µL 5X Second 
Strand Buffer (Invitrogen), 3.0 µL 10 mM dNTP mix, and 4.0 µL of E. coli DNA Polymerase I 
(Invitrogen) to final volume of 150 µL.  Second-strand reactions were incubated for 2 h at 16 °C, 
supplemented with 2.0 µL T4 DNA Polymerase (Fermentas) and incubation at 16 °C for 10 min 
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and then chilled on ice.  cDNA samples were purified using the Affymetrix cDNA Cleanup Kit 
(Affymetrix) according to the manufacturer's direction. 
  2.4.5 Preparation of Double-Stranded cDNA from Oocyte Total RNA – 
Synthesis of double-stranded cDNA incorporating a T7 promoter from total oocyte RNA was 
achieved similarly to the first-cycle reverse transcription of immunoprecipitated mRNA 
discussed in section 2.4.2 with some modifications.  RNA samples stored as the ethanol 
precipitate were centrifuged (20,000 X g, 20 min, 4 °C), and pellets were dried briefly to remove 
excess ethanol and resuspended in nuclease-free water. RNA concentrations were determined by 
UV spectrophotometry, sample volumes adjusted to 5 µg total oocyte RNA per 10 µL, and 
combined with 2.0 µL “poly-A spike-in control RNA” (Affymetrix) and 2.0 µL of 50 µM Oligo-
dT/T7 primer.  The mixture was heated at 70 °C for 10 min and then chilled on ice for 5 min.  
Reverse transcription reactions were assembled by addition of 4.0 µL 5X First Strand Buffer 
(Invitrogen), 2.0 µL of 0.1 M DTT, 1.0 µL (40 U) of RNase inhibitor (Fermentas), 1.0 µL of 10 
mM dNTPs, and 2.0 µL of SuperScript Reverse Transcriptase (Invitrogen) for a final volume of 
20 µL.  Reactions were incubated at 25 °C for 10 min, 42 °C for 1 h, then heated at 70 °C for 10 
min to inactivate Reverse Transcriptase, and chilled on ice.  Second strand synthesis reactions 
were assembled by addition of the following to the chilled first strand reaction (20 µL): 9.6 µL 
RNase-free water, 8.0 µL of 17.5 mM MgCl2, 0.8 µL of 10 mM dNTP mix, 1.2 µL E. coli DNA 
Polymerase I (Invitrogen) and 0.4 µL RNase H (Invitrogen).  Reactions were incubated at 16 °C 
for 2 h, supplemented with 2.0 µL T4 DNA Polymerase (Invitrogen), incubated for an additional 
10 min at 16 °C, then heated to 75 °C for 10 min and chilled on ice. cDNA samples were purified 
using the Affymetrix cDNA Cleanup Kit (Affymetrix) according to the manufacturer's direction. 
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2.4.6 Synthesis of Biotinylated RNA and DNA Microarray Analysis - Production of 
biotinylated cRNA for gene chip analysis was performed using the Affymetrix Gene Chip IVT 
Labelling Kit (Affymetrix) according to the manufacturer's directions.  Briefly, all the amplified 
cDNA obtained from either the two-cycle amplification procedure or the single-cycle procedure 
used with total oocyte mRNA described above was combined with 4.0 µL 10X IVT Reaction 
Buffer, 12 µL IVT Labelling NTP Mix, and 4.0 µL IVT Enzyme Mix and RNase-free water to 
make a final volume of 40 µL.  In vitro transcription reactions were incubated at 37 °C for 16 h.  
The resulting biotinylated cRNA samples were purified using the Affymetrix cRNA Purification 
Kit (Affymetrix) according to the supplied directions.  Aliquots were diluted 1/50 in RNase-free 
water and RNA quantified by UV spectrophotometry using a BioRad SmartSpec Plus 
spectrophotometer (BioRad) and a conversion ratio of 40 µg ssRNA per OD unit at 260 nm.  All 
samples exceeded the minimum OD260/OD280 ratio of 1.8 required for gene chip analysis.  
Integrity and quantity of in vitro-transcribed cRNA was verified by electrophoresis on 1% 
agarose-TAE gels containing 0.5 µg/mL ethidium bromide.  Microarray analysis was performed 
by Genome Explorations Inc, Memphis, TN using the Affymetrix Xenopus Genome 2.0 
oligonucleotide microarray. 
  2.4.7 Treatment of DNA Microarray Data – Computerized data manipulations 
were performed by Mr. Justin Guenther using MATLAB® software package and software 
written in the Perl programming language (Lab of Dr. N. Ovsenek, Department of Anatomy and 
Cell Biology, University of Saskatchewan) in accordance with the published literature (Vallee et 
al., 2008).  For total mRNA analysis, control (total) mRNA from five replicate females, and YY1 
IP mRNA from three replicate females were analyzed by DNA microarray. Normalized signal 
intensities from each replicate array were averaged to generate the Control and YY1 IP data sets.  
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Data was divided into two categories: Positives (mRNAs predicted to associate with YY1) and 
Negatives (mRNAs predicted not to associate with YY1 but present in the oocyte pool).  Positive 
results encompassed spots that had log signal intensity > 3 in the Control data set and > 3.17 in 
the YY1 IP data set.  Negative results encompassed spots that had log signal intensity > 3 in the 
Control data set and < 2.7 in the YY1 IP data set.  Gene sequences of Xenopus laevis are not 
currently annotated with Gene Ontology (GO) terms.  Therefore, in order to associate functions 
with the products of mRNAs bound by YY1 in oocytes, it was necessary to align the sequences 
of mRNAs detected in YY1 IPs with the more fully annotated Mus musculus nucleotide 
sequence database.   Xenopus laevis sequences were aligned with the NR database at NCBI.  
Protein accession numbers in the UniProt database were retrieved for BLAST hits with 
alignment expectation values to Mus musculus less than 1 x 10-20.  GO terms associated with the 
highest scoring BLAST hit for each sequence were tallied from annotation data in the UniProt 
database. 
  2.4.8 Ver ification of Gene Chip data by Real Time PCR – For Real Time PCR 
analysis, mRNA was isolated from immunoprecipitation reactions as described above (2.4.1).  
Reactions containing five oocyte equivalents immunoprecipitated mRNA or total oocyte RNA, 
and 0.5 µg Oligo-dT(18) primer in a volume of 10 µL RNase-free water were heated at 70 °C for 
10 min and then chilled on ice.  Reverse transcription reactions were assembled by adding 2 µL 
10X RT buffer (Fermentas), 200 µM dNTPs, 40 U RNase inhibitor (Fermentas), and 200 U 
MLuV H- Reverse Transcriptase (Fermentas) in a final volume of 20 µL and incubated at 42 °C 
for 1 h.  Reverse transcriptase reactions were terminated by heating at 70 °C for 10 min followed 
by chilling on ice.  The resulting cDNA was diluted with 30 µL water and one microliter of the 
resulting cDNA was used in each PCR reaction.  PCR reactions contained 1 X SYBR green/Taq 
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Polymerase master mix (Fermentas), 0.2 µM forward and reverse primer, 0.2 mM dNTPs, and 
0.1 oocyte equivalent cDNA.  Reactions were conducted using a Bio-Rad iCycler® (Bio-Rad) 
quantitative PCR instrument.  Data was analyzed according to Pfaffl et al. (Pfaffl, 2001) using 
the Bio-Rad CFX Manager® software package (Bio-Rad).  Presented data is the average of three 
replicates using starting RNA from oocytes of three separate females. 
 2.5 Analysis of Nucleocytoplasmic distr ibution of YY1 in cultured cells 
  2.5.1 Cell lines, culture conditions, and preparation of lysates – Human 
hepatocellular carcinoma HepG2 cells were cultured in DMEM media (Sigma) containing 10% 
(v/v) foetal bovine serum (Sigma) and supplemented with penicillin/streptomycin.  Xenopus A6 
kidney epithelial cells were cultured at 26 °C in 85% (v/v) MEM containing 10% (v/v) foetal 
bovine serum and supplemented with penicillin/streptomycin.  Whole cell extracts were prepared 
by homogenization in 400 mM NaCl, 20 mM HEPES (pH 7.9), 1 mM EDTA, 1 mM DTT, 10 % 
(v/v) glycerol, 1X protease inhibitor cocktail (Sigma) followed by centrifugation at 15,000 X g 
for 15 min at 4 °C.  Nuclear and cytoplasmic extracts were prepared by a modification of the 
method of Dignam et al. (Dignam et al., 1983).  Cells were harvested by trypsinization and 
collected by centrifugation (800 X g, 5 min, 4 °C) and were washed once in phosphate buffered 
saline.  Cell pellets were gently resuspended in 500 µL buffer A (10 mM KCl, 10 mM HEPES 
(pH 7.9), 1 mM EDTA, 1 mM DTT, 0.5% (v/v) triton X-100, 1X protease inhibitor cocktail 
(Sigma)) and agitated by end-over-end rotation at 4 °C for 10 min.  Nuclei were collected by 
centrifugation (1000 X g, 5 min, 4 °C) and the supernatants containing the cytoplasmic fractions 
removed and saved.  The cytoplasmic fraction was then mixed with 60 µL of buffer B (1.4 M 
KCl, 300 mM HEPES (pH 7.9)) and 50 µL glycerol, vortexed vigorously, and centrifuged at 
15,000 X g for 15 min at 4 °C.  The supernatants, comprising the final cytoplasmic extracts, were 
 47 
 
stored at -80 °C until use.  The pelleted nuclei were washed by gentle resuspension in buffer A 
followed by a second centrifugation at 1000 X g for 5 min at 4 °C.  Washed nuclei were then 
suspended in 250 µL Buffer C (400 mM NaCl, 20 mM HEPES (pH 7.9), 1 mM EDTA, 1 mM 
DTT, 10 % (v/v) glycerol, 1X protease inhibitor cocktail) and homogenized with ten strokes of a 
Dounce homogenizer.  Homogenates were centrifuged (15,000 X g, 15 min, 4 °C) and the 
supernatants stored at -80 °C until use.   
  2.5.2 EMSA analysis of YY1 DNA- and RNA- binding Activity in Culture Cell 
Lysates – EMSA analysis of YY1 DNA- and RNA-binding activity in lysates of cultured cells 
was performed essentially as described in section 2.3.2.  Protein concentrations in lysates were 
determined by the method of Bradford (Bradford, 1976) and concentrations were adjusted to 4 
µg/µL.  In contrast to binding reactions using recombinant YY1, binding reactions using cell 
lysates contained 0.5 µg poly-dIdC (GE Life Science) and 20 µg protein (5 µL lysate) in a final 
volume of 20 µL.   
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3. Results 
3.1 Pur ification and Renaturation of Recombinant YY1 - The initial sections of 
the results describe parameters for effective in vitro production of YY1, a zinc finger nucleic 
acid-binding protein with structural features requiring optimization of purification and 
renaturation protocols. 
  3.1.1 Lysis Buffer Efficiency – YY1-expressing bacteria were lysed in four 
different lysis buffers, and both soluble and insoluble fractions were analyzed by Western 
blotting (Figure 2A).  In controls, sonication of cells suspended in simple buffers lacking lysis 
reagents resulted in the majority of recombinant protein remaining in the pellet (Figure 2A).  
Addition of lysozyme did not result in a substantial increase in levels of recombinant protein in 
the soluble fraction (Figure 2A), despite verification of the activity of this lysozyme according to 
Zinder et al. (Zinder and Arndt, 1956) (data not shown).  The majority of recombinant YY1 was 
present in the soluble fraction with lysis buffers containing either 6 M guanidium hydrochloride 
or 8 M urea. 
  3.1.2  Effect of Reducing Agents on YY1 in Bacter ial Lysates – In relatively 
concentrated protein solutions under non-denaturing conditions proteins are susceptible to 
formation of intermolecular as well as intramolecular disulfide bonds (Andersson, 1969; 
Andersson, 1970).  This issue was examined with respect to YY1 by analysis of lysates prepared 
in the absence or presence of either 2-mercaptoethanol or hydrogen peroxide.  Oxidation-
dependent aggregation was assessed by removing aliquots at the indicated time points and 
analysis by Western blotting under non-reducing conditions.  Non-reducing gels were used in 
order to detect aggregated YY1 that could potentially be formed in lysates lacking reducing 
agents (Andersson, 1969; Andersson, 1970).  No significant degradation products or higher 
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molecular weight aggregates of recombinant YY1 were detected in the presence of 2-
mercaptoethanol (Figure 2B, upper two panels), whereas high molecular mass aggregates were 
detected after as little as 1 h of room temperature incubation in the absence of 2-mercaptoethanol 
(Figure 2B, middle two panels).  Formation of aggregates was shown to be dependent on protein 
oxidation since supplementation of buffer with the oxidising agent hydrogen peroxide resulted in 
similar aggregation of YY1 after 1 h (Figure 2B, lower two panels).  It is hypothesized that 
oxidation of key cysteine residues responsible for co-ordination of zinc ions in the zinc-finger 
regions of the protein could account for the sensitivity of YY1 to oxidation.  In no case were 
lower molecular mass bands detected that would suggest proteolytic degradation of recombinant 
YY1 under these conditions. 
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Figure 2 – Effect of Lysis Buffer Composition on YY1 Solubility and Stability.  (A) YY1-
expressing E. coli were lysed directly in SDS-PAGE loading buffer containing 8 M urea (control, 
C) or in Lysis Buffers I – IV as indicated above the panel (see materials and methods for buffer 
compositions). Lysis Buffer I contained 300 mM NaCl, Buffer II was 300 mM NaCl + 
Lysozyme, Buffer III contained 6 M guanidine hydrochloride, and Buffer IV contained 8 M urea 
+ 1 % SDS. Insoluble (P, pellet) and soluble (S, supernatant) fractions were separated by 
centrifugation and analyzed by Western blotting using anti-HIS6 tag (αHIS6) or anti-YY1 
(αYY1) antibodies. (B) Effect of reducing agents on YY1 aggregation in lysates prepared in 
Lysis buffer IV were analyzed by Western blotting following electrophoresis on non-denaturing 
SDS-PAGE gels.  Lysates were prepared in the presence (+2ME) or absence (-2ME) of 2-
mercaptoethanol or in the presence of hydrogen peroxide (+H2O2).  Temperature and duration of 
incubation in hours is indicated above the panel.  (RT, room temperature; 37 °C). Control lysates 
(C) were prepared directly in SDS-PAGE loading buffer containing 8 M urea without 2-
mercaptoethanol.  
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  3.1.3 Immobilized Metal Affinity Chromatography of YY1 – Lysates in buffer 
containing 4 M urea, 300 mM NaCl, 50 mM Phosphate buffer, 0.5 % SDS and 2-
mercaptoethanol were applied to nickel-charged NTA-agarose columns by recirculation.  It was 
determined empirically that increased purity of recombinant protein could be achieved using 
wash buffers with higher concentrations of imidazole than those recommended by the 
manufacturer.  Inclusion of 20 mM imidazole in Wash Buffers resulted in eluted protein with >95 
% purity as compared to approximately 80-90 % purity with standard wash buffers (data not 
shown).  The use of 4-8 M urea in lysis and wash buffers is purported to enhance the specificity 
of binding of HIS-tagged proteins to metal-charged affinity columns (Esfandiar et al., 2010; Zhu 
et al., 2005).  Under these conditions, metal ion-binding proteins of bacterial origin are denatured 
while the HIS-tag moiety retains the capacity to complex with immobilized metal ions on the 
matrix.  Initial experiments with YY1 isolation employed wash buffers containing 4 M urea.  
However, due to the large quantities of urea required (960 g for a 4 L carboy of buffer) the 
efficacy of wash buffers lacking denaturants was examined further.  Whereas urea enhanced the 
specificity of recombinant YY1 binding to columns in load-on procedures when included in lysis 
buffers, it did not significantly enhance purity and yield when included in wash buffers (data not 
shown).  Contrarily, adjustment of imidazole concentrations in wash buffers had the greatest 
effect on purity of recombinant protein eluted from the column (data not shown).  Use of 
guanidium hydrochloride as a denaturant in wash and elution steps resulted in significant leakage 
of nickel ions from the column matrix as determined by spectroscopic analysis (data not shown), 
the impact of which is discussed in section 3.1.4 below. 
A systematic comparison of elution buffers demonstrated that imidazole was 
superior to pH elution using either acetate or 2-(N-morpholino)ethanesulfonic acid (MES) 
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buffers.  In the case of YY1, pH elution resulted in precipitation near its isoelectric point (pH 
5.8).   Whilst not applicable to YY1, pH elution remains highly desirable in many applications 
since it obviates removal of imidazole which is a potential inhibitor of certain protein functions.  
Elution of YY1 into ten 5 mL fractions was performed with buffer containing 200 mM imidazole 
(pH 8.0).  Rather than bulk elution, selection of fractions containing peak concentrations of 
protein facilitated more concentrated final protein product, and this practice eliminated time 
consuming protein concentration steps.  While a small quantity of protein was observed to elute 
into early fractions (Figure 3B) the majority of recombinant protein eluted into fraction numbers 
5-8 (Figure 3).  Western blotting showed that fraction 7 contained the bulk of eluted YY1 protein 
(Figure 3B) and this fraction was used for subsequent renaturation. 
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Figure 3
  
 – Imidazole-Elution of YY1 from IMAC Resins.  (A) Ten 5 mL fractions were 
collected during elution of YY1-loaded IMAC columns with 200 mM imidazole for 
determination of protein concentrations.  Fraction numbers are plotted on the x-axis, protein 
concentration in µg/mL is plotted on  the y-axis.  (B) Fractions were analyzed by Western 
blotting using anti-YY1 antibody (αYY1).  Fraction numbers are indicated above the panel. 
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 3.1.4 Renaturation of YY1 – An empirical approach to achieving optimal activity of 
recombinant YY1 showed the need for removal of nickel ion contamination in eluants.  Optimal 
results were obtained through a procedure involving initial denaturation of eluted protein with 
simultaneous chelation of nickel and other potential contaminants, followed by renaturation. 
Column fractions containing YY1 were supplemented with solid guanidium 
isothiocyanate (as a denaturant) to a final concentration of 6 M and EDTA to a final concentration 
of 25 mM.  Addition of 6 M guanidium isothiocyanate resulted in effective denaturation of YY1 
as demonstrated by diagnostic DNA EMSA analysis of aliquots of guanidium supplemented 
fractions (Figure 4B).  Samples were supplemented with EDTA in order to complex residual 
nickel ions from the IMAC step that inhibit YY1 nucleic acid binding activity (Figure 4C).  YY1 
was renatured by stepwise buffer exchange using a centrifugal dialysis device.  Progressive 
renaturation of YY1 though stepwise buffer exchange was monitored by nitrocellulose filter 
binding assays and EMSA analysis.  As determined by these assays, YY1 renatured as the 
guanidium concentration was reduced from 750 mM to 94 mM with no further increases in 
activity noted below 94 mM (Figure 4A and B). 
Nickel-charged NTA-agarose generally exhibits low leakage of nickel ions into 
solution at pH 8.0 (Belew et al., 1987).  Free nickel at low concentrations could conceivably bind 
to proteins possessing zinc-fingers, potentially inhibiting activity of target proteins.  Indeed, 
spectroscopic analysis of eluants revealed the presence of the Ni2+ ion (data not shown).  Addition 
of 1 mM nickel sulphate to binding reactions containing YY1 significantly decreased its activity 
(Figure 4C) demonstrating that the presence of relatively small amounts of nickel ions inherent to 
the IMAC procedure can inhibit the DNA-binding activity of YY1 in vitro, presumably through 
inhibition of zinc-finger function.  Addition of EDTA to eluants prior to renaturation was 
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necessary to attain full activity of recombinant YY1 protein, suggesting this step effectively 
removes bound nickel from recombinant YY1. 
The importance of maintaining reducing conditions during the isolation and 
renaturation of YY1 is demonstrated by the experiments in Figure 4C.  Renaturation of YY1 in 
the absence of 2-mercaptoethanol resulted in significantly lower activity compared to renaturation 
under mild reducing conditions (Figure 4C).  Subsequent addition of hydrogen peroxide to active 
YY1 resulted in a decline in DNA-binding activity to a level that was barely detectable by EMSA 
(Figure 4C).  Collectively these data demonstrate the importance of considering redox and metal 
ion effects on YY1 activity.  
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Figure 4
  
 – Renaturation of Recombinant YY1.  YY1 was renatured through stepwise (10) 
exchange of buffer starting from 6 M guanidium isothiocyanate with 50% dilution of guanidium 
at each step.  (A) Aliquots of YY1 from each step were analyzed for DNA-binding activity by 
nitrocellulose filter binding assays containing 10 nM labeled YY1 DNA element.  The logarithm 
of guanidium isothiocyanate concentration at each step of buffer exchange is plotted on the x-
axis.  Concentration of YY1-DNA complex formed in each aliquot is plotted on the y-axis.  (B) 
Renaturation of YY 1 was analyzed by EMSA using labeled YY1 DNA element (upper panel).  
Presence of YY1 in the analyzed fractions is demonstrated by SDS-PAGE of aliquots followed 
by staining with Coomassie Blue (lower panel).  (C) Effect of redox conditions and free nickel 
on YY1 DNA-binding activity assayed by EMSA.  The DNA-binding activity of YY1 renatured 
under ideal conditions (control, C) is compared to the activity of YY1 supplemented with 1 mM 
hydrogen peroxide (+H2O2), renatured in the absence of 2-mercaptoethanol (-2ME), or 
supplemented with 1 mM nickel sulfate (+NiSO4). 
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3.2 YY1 Possesses Sequence-Specific RNA Binding Activity 
3.2.1 Analysis of Recombinant YY1 – Following bacterial expression and 
purification of His6-tagged Xenopus YY1 (Figure 5A), activity of the recombinant protein was 
verified by DNA-binding assays using the consensus promoter element.  YY1 required the 
presence of both zinc and magnesium ions for DNA binding (Figure 5B).  Empirical 
experimentation revealed that, at minimum, concentrations of 1 mM magnesium and 50 µM zinc 
were required for activity.  Subsequently, the renaturation buffer used was standardized at 
concentrations of 2 mM magnesium and 0.2 mM zinc respectively.  Formation of YY1-DNA 
complexes was competed with both oligonucleotide and antibody competitors (Figure 5B) in a 
manner similar to that of endogenous YY1 (Ficzycz et al., 2001).  Recombinant YY1 bound with 
high affinity to the consensus YY1-DNA element and with considerably less affinity to a mutated 
consensus DNA probe (Figure 5C), as observed in previous studies using mammalian YY1 
(Momoeda et al., 1995; Yant et al., 1995).  No binding activity was observed with single-
stranded forward and reverse strands of either consensus or mutant DNA probes (data not 
shown).  Therefore, YY1 did not possess affinity for single-stranded DNA. 
Nitrocellulose filter binding reactions were used for comparative determination of 
dissociation constants of various probes and to quantitatively verify the results of the EMSA 
analysis.  The filter binding assay measures the proportion of the total radioactivity bound, which 
is converted to a molar quantity of bound probe as a function of the specific activity.  High 
affinity of YY1 for consensus DNA probe was verified by filter binding assay (Kd = 3.2 ± 0.1 
nM, Table 2).  Moderate to low affinity binding to mutant probe (Kd = 54.9 ± 1.2 nM) and no 
detectable binding to heat shock element DNA were observed (Figure 5C and Table 2).  
Experiments employing modified EMSA protocols showed that YY1 did not exhibit free 
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nucleotide binding activity to adenosine, uridine, or deoxycytidine triphosphates (data not 
shown). 
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Figure 5 – Pur ity and DNA-binding Activity of Recombinant YY1. (A) Western blots of 
bacterial YY1 expression (top panel) and purification (bottom panel). Hours after addition of 
isopropyl-1-thio-β-D-galactopyranoside to log phase cultures are indicated at top. Purity of 
eluted protein was verified by silver staining after SDS-PAGE (right panel). LO, load on; FT, 
flow through and wash; EL, eluant. The position of molecular mass markers are indicated. (B) 
EMSA was performed with 100 nM YY1 and 10 mM consensus DNA probe. Requirement of 
zinc and magnesium for DNA binding of the recombinant protein is demonstrated in the upper 
panel and specificity of DNA binding in the lower panel. Recombinant protein was renatured in 
the presence of 0.1 mM EDTA prior to use in binding reactions, and reactions were then 
supplemented with zinc (0.2 mM) and/or magnesium (2 mM). To demonstrate sequence-specific 
DNA-binding, protein renatured in the presence of 0.2 mM zinc and 2 mM magnesium was used 
in binding reactions containing the following competitors: No competitor (NC), 1 pmol of 
double-stranded YY1 consensus (YY1C) or mutant (YY1M) DNA, 200 ng YY1 (αYY1) or 
PCNA (αPCNA) antibodies. (C) Varying concentrations of YY1 (indicated above panel) were 
combined in binding reactions with 10 nM consensus DNA (YY1C) or mutant consensus DNA 
(YY1M) probes and analyzed by EMSA.  
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3.2.2 Analysis of YY1 RNA-Binding Activity – In order to test the hypothesis 
that YY1 possesses RNA-binding activity, recombinant YY1 was combined with selected RNA 
probes in binding reactions and then analyzed by EMSA.  Probes were chosen that possessed a 
uniform nucleotide composition (~ 50 % G/C content), were of appropriate size for use in EMSA 
analysis (< 200 nt), and were either relatively unstructured (β-Globin and GAPDH 3’-UTRs) or 
possessed significant secondary structure (5S rRNA).  It should be noted that none of these 
probes were, or are necessarily suspected of being endogenous substrates of YY1 in vivo, but 
were chosen for initial analysis of YY1 RNA-binding activity because of their ready availability 
and the properties discussed above.  Specifically, the probes used spanned the 3’-UTR of 
Xenopus GAPDH (136 nt) and β-Globin (130 nt), and the full length of the Xenopus 5S rRNA 
molecule (121 nt).  The GAPDH and β-Globin probes are predicted to have little secondary 
structure, whereas the 5S rRNA contains significant secondary structure (Romaniuk, 1985).  
RNA binding reactions containing these probes were analyzed by RNA mobility shift assay.  
Analysis of binding reactions containing 0.5 µM recombinant YY1 and 10 nM radiolabelled 
GAPDH or β-Globin probe revealed that each formed a single prominent retarded complex that 
was specifically competed by addition of 1 pmol unlabelled YY1 consensus DNA (Figure 6).  
Under the same conditions, YY1 formed multiple complexes with the 5S rRNA which were 
competed by consensus DNA element (Figure 6).  These data demonstrate that YY1 has the 
capacity to bind to disparate nucleotide sequences of both unstructured and highly structured 
RNAs. 
To determine unequivocally the identity of the complexes described above, 0.5 
µM recombinant YY1 was combined with 10 nM radiolabelled β-globin probe in the presence or 
absence of zinc and magnesium as well as with specific and non-specific competitors (Figure 7).  
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Complex formation depended on the presence of both zinc and magnesium ions.  Furthermore, 
addition of YY1-consensus DNA competitor, or anti-YY1 antibody, reduced or abolished 
complex formation.  Nonspecific competitors had no effect.  These data are similar to what has 
been observed previously with the YY1-DNA interaction in that both magnesium and zinc are 
required for full binding activity, and also that addition of anti-YY1 antibody interferes with 
nucleic acid binding (Ficzycz et al., 2001). 
Although the data presented above suggest that YY1 may interact with internal 
regions of RNA molecules, the possibility remains open that YY1 association with RNA could be 
affected by the presence or absence of the eukaryotic mRNA 5’ 7-methylguanosine cap structure.  
The effects of 5’-cap modifications on YY1-RNA interactions were investigated using GAPDH 
and β-Globin RNA probes.  Probes were prepared in the presence or absence of cap analogue, 
and the relative affinity for YY1 was analyzed in RNA-binding reactions containing a range of 
YY1 concentrations.  RNA binding reactions were subjected to both EMSA and nitrocellulose 
filter binding assays (Figure 8 and Table 2).  The analysis revealed no significant difference in 
binding affinity of YY1 to capped versus uncapped probes, either visible on the RNA-shift gel or 
in filter binding assays.  Nitrocellulose filter binding assays yielded Kd values as follows:  
GAPDH uncapped, 14.9 ± 2.4 nM and capped, 17.4 ± 3.6 nM; β-globin uncapped, 47.8 ± 2.5 nM 
and capped, 49 ± 2.9 nM.  Therefore, it is unlikely that interaction of YY1 with mRNAs in vivo 
involves direct recognition of the 7-methylguanosine cap structure.  The affinity of YY1 for 5S 
rRNA was also determined (Figure 8 and Table 2) as 11.5 ± 2.9 nM.  While apparent affinity of 
YY1 for 5S rRNA was higher than for either the GAPDH or β-globin probes, YY1 formed a 
number of distinct complexes with 5S rRNA, with a greater number of complexes appearing in 
reactions containing higher concentrations of YY1 (Figure 8).  
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Figure 6
  
 - Analysis of YY1 RNA-Binding Activity. RNA-binding reactions containing 10 nM 
probe (indicated at bottom) in the presence (+) of 100 nM YY1 protein with addition (+) of 1 
pmol double-stranded YY1 consensus DNA competitor (YY1E DNA) were analyzed by EMSA. 
Positions of YY1-RNA complexes and unbound free probe are indicated at left. 
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Figure 7
  
 - Effect of Magnesium and Zinc Ions on RNA-Binding Activity of YY1. RNA-
binding reactions containing 100 nM YY1 and 10 nM labelled β-Globin 3'UTR probe were 
subjected to EMSA. Binding reactions were carried out in the presence or absence of 0.2 mM 
zinc and/or 2 mM magnesium. Specificity of RNA-binding was analyzed by addition of 
competitors to binding reactions; no competitor (NC), 1 pmol of double-stranded YY1 consensus 
(YY1E) or mutant (YY1M) DNA, 200 ng of YY1 (αYY1) or PCNA (αPCNA) antibodies. The 
postition of the YY1-RNA complex and free probe are indicated at left. 
 69 
 
 
 70 
 
Figure 8 - Affinity of YY1 for Selected RNA Probes and Effect of 7-Methylguanosine Cap 
Structure on Substrate Binding Affinity of YY1. (A) RNA-binding reactions containing a 
range of YY1 concentrations (indicated at the top) and 10 mM RNA probe (indicated at left) 
were analyzed by EMSA. 5'-capped (+) or uncapped (-) probes are indicated at left. (B) Binding 
reactions were analyzed by filter binding assays and the Kd values are presented graphically. 
RNA or DNA probe substrate is indicated beneath the bar graph. For GAPDH and β-Globin, 
uncapped and capped probes are represented by white and black bars, respectively. 
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3.2.3 YY1 Has High Affinity for U-r ich RNA Substrates – The experiments 
described in section 3.2.2 demonstrate that YY1 has the ability to form intermolecular complexes 
with RNA; however, they shed little light on the substrate specificity of YY1.  The following 
experiments analyze the affinity of YY1 for short (20 nucleotides) synthetic single-stranded and 
double-stranded oligoribonucleotide substrates with various sequences.  One hypothesis was that 
YY1 may bind to RNA sequences complementary to the consensus DNA promoter element.  To 
test this hypothesis binding reactions were assembled with various concentrations of YY1 and 
RNA probes containing the DNA consensus site (See Table 1) and analyzed by EMSA and filter 
binding assays. YY1 binding to single-stranded consensus as well as mutant RNA probes was 
barely detectable, and YY1 bound very weakly to both consensus and mutant duplex RNA 
probes (Figure 9 and Table 2). 
The next experiments measured YY1 affinity for 20 nucleotide homopolymeric 
and heteropolymeric synthetic RNAs.  Full descriptions of oligonucleotides used are provided in 
Table 1.  EMSA and filter binding assays revealed high affinity of YY1 for U20 (Kd = 1.2 ± 0.2 
nM), moderate affinity for A20 (Kd = 24.8 ± 1.3 nM), weak affinity for G20 (Kd = 114 ± 4 nM), 
and no detectable binding was observed with C20 (Figure 10 and Table 2).  Analysis of binding to 
G20 by EMSA was not in accordance with filter binding data.  It is surmised that gel shift assays 
were complicated by the presence of excessive secondary structure present in this probe, a 
postulate that is supported by the fact this probe was resistant to RNase T1 digestion (data not 
shown).  It should also be noted in Figure 10 that in G20 containing binding reactions complex 
formation was not concentration-dependent with respect to YY1. 
Next, YY1 affinity for the single-stranded dinucleotide combinations (AC)10, (AG)10, (CU)10, 
and (GU)10 were analyzed (Sequences in Table 1).  The dinucleotide combinations (AU)10 and 
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(GC)10 form self-complementary duplexes and are analyzed below.  YY1 bound to (GU)10 with 
moderate affinity (Kd = 38.0 ± 1.5 nM), (CU)10 and (AG)10 with low affinity, and no binding to 
(AC)10 was detected (Figure 10 and Table 2).  These data reveal a preference for U-rich single-
stranded probes. 
  The effect of RNA secondary structure on YY1 was examined in greater detail 
using duplex-forming RNA oligonucleotides.  Six possible duplexes can be made from the 
homopolymeric and dinucleotide heteropolymeric RNAs described above (see Table 1).  Each of 
these was prepared by labelling one of the two strands and annealing to the unlabelled 
complementary strand.   In each case reciprocal experiments with the other strand labelled were 
performed to ensure the measured affinity was for the double-stranded probe.  Additionally, 
double-strandedness was further verified by digestion with RNase A or T1 as appropriate (data 
not shown).  YY1 bound with high affinity to the A:U duplex (Kd = 3.4 ± 0.1 nM), whereas 
binding to the C:G duplex was barely detectable by EMSA (Figure 10 and Table 2).  No 
significant binding of YY1 to (AU):(AU), (GC):(GC), (AG):(CU), or (AC):(GU) RNA duplexes 
was observed in either EMSA or nitrocellulose filter binding assay (Table 2).  Overall, the results 
shown in Figure 10 and the associated Kd values given in Table 2 demonstrate that YY1 exhibits 
direct, high affinity RNA-binding activity with some degree of sequence specificity toward U-
rich substrates.  
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Figure 9 - Affinity of YY1 for RNAs Containing the YY1 DNA Consensus Sequence. RNA-
binding reactions containing a gradient of YY1 concentrations (indicated at top) and 10 nM RNA 
probe (indicated at left) were subjected to EMSA. Probes used were: CF/R RNA, single stranded 
RNAs containing the YY1 DNA consensus sequence (F) or its reverse compliment (R); MF/R, 
single stranded RNAs containing the YY1 mutant DNA consensus sequence (F) or its reverse 
compliment (R); ds C RNA, double stranded RNA containing YY1 DNA consensus sequence; 
and ds M RNA, double stranded RNA containing YY1 mutant DNA consensus sequence. Full 
sequences and descriptions of probes used are given in Table 1.  
 75 
 
 
 76 
 
Figure 10
 
 - Affinity of YY1 for Structurally Diverse Single Stranded and Double Stranded 
RNAs. RNA-binding reactions containing a gradient of YY1 concentrations (indicated at top) 
and 10 nM RNA probe (indicated at left) were subjected to EMSA. Probes used were: 
A/U/G/C(20), homopolymeric RNA 20-mer of the indicated nucleotide; AC/GA/CU/GU(10), 
hetropolymeric RNA 20-mer consisting of 10 repeats of the indicated dinucleotide; rA:rU, 
double stranded RNA consisting of U(20) hybridized to A(20); rC:rG, double stranded RNA 
consisting of C(20) hybridized to G(20). Full sequences and descriptions of probes used are 
given in Table 1. Only RNA substrates for which YY1 showed detectable binding by EMSA are 
shown. 
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3.2.4 Stability of YY1-RNA Interactions – The affinity of YY1 for U-rich 
RNA substrates is described in section 3.2.3.  To further characterize the RNA-binding activity of 
YY1, a radiolabelled U20 oligonucleotide probe (see Table 1) was used in binding reactions with 
recombinant YY1 under various conditions of temperature, ionic strength, and in the presence of 
detergents (Figure 11A).  These experiments provide insight into the stability of YY1-RNA 
interactions as well as providing information to guide the design of further experiments.  In RNA 
mobility shift assays, the relative amounts of detectable YY1-RNA complexes were highest 
when binding reactions were carried out at low temperature (0 – 4 °C).  Only a slight decrease in 
complex stability was detected between 20 and 45 °C, and significant complex formation was 
still evident at 55 °C.  These data demonstrate that YY1-RNA complexes are stable at 
temperatures within the physiological range of Xenopus oocytes, embryos, and adult tissues (12 
– 25 °C).  The persistence of RNA-binding activity at temperatures above this range is indicative 
of the thermodynamic stability of YY1-RNA complexes. 
 The ionic stability of YY1-RNA interactions was examined through a range of 
NaCl concentrations.  YY1-RNA complexes appeared to be relatively stable up to 800 mM NaCl 
(Figure 11B).  The ionic stability of YY1-RNA interactions in vitro were compared to the 
stability of YY1-RNA interactions in native mRNPs through the use of oligo-dT cellulose 
chromatography of oocyte lysates (Ficzycz and Ovsenek, 2002).  In this assay, YY1-mRNPs are 
immobilized on oligo-dT cellulose matrix by virtue of the high-affinity interaction between the 
poly-T tracts of the matrix and the poly-A tails of mRNAs in YY1-containing mRNPs formed in 
vivo during oogenesis.  Elution of YY1 from immobilized mRNPs using a NaCl gradient is an 
indirect measure of the stability of YY1-RNA interactions in vivo.  YY1 disassociated from RNA 
at an NaCl concentration of approximately 600 mM to 800 mM (Figure 11C), similar to the 
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concentrations of NaCl that were shown to destabilize YY1-RNA interactions formed in in vitro 
binding reactions (Figure 11B).  These data show that YY1-mRNA interactions formed in 
oocytes are extremely resistant to ionic perturbation, and suggest that once formed, YY1-mRNPs 
are highly stable complexes.  Furthermore, these data support the hypothesis that the properties 
of recombinant YY1 analyzed by RNA-EMSA are representative of the properties of endogenous 
YY1 in complex with RNA in mRNPs in vivo. 
 The stability of the YY1-RNA interaction was further tested using detergents that 
destabilize hydrophobic intra- and inter-molecular protein interactions.  YY1-RNA binding 
reactions were carried out in the presence of 0.01 % (w/v), 0.1 % (w/v) or 1 % (w/v) of Tween-
20, Nonidet P-40, and SDS (Figure 11D).  YY1-RNA complex formation was not disrupted by 
Tween-20, whereas a slight reduction in complex formation was observed with Nonidet P-40 
above 0.1 %.  Thus, the YY1-RNA interaction is stable in the presence of non-ionic detergents.  
SDS, a powerful ionic detergent, prevented complex formation at concentrations above 0.01 %, 
presumably via denaturation of YY1.  Overall, the data presented in Figure 11 demonstrate that 
YY1-RNA interactions are highly stable under a wide range of harsh thermal and ionic 
conditions.  These data were particularly useful in guiding the formulation of buffer 
compositions used in subsequent immunoprecipitation and analysis of YY1-mRNPs (see below).   
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Figure 11
  
 - Thermal, Detergent, and Ionic Stability of YY1-RNA Interaction. RNA-binding 
reactions containing 100 nM YY1 and 10 mM poly-U(20) RNA probe were subjected to EMSA. 
(A) Binding reactions were carried out at the temperatures indicated above the panel. The 
positions of YY1-RNA complex and free probe are indicated. P, probe only; C, complex; FP, 
free probe. (B) Reactions were preformed with concentrations of sodium chloride as indicated 
above the panel. P, probe only. (C) Oocyte lysates were loaded onto oligo-dT cellulose and 
Western blotting analysis was performed on protein fractions eluted with a sodium chloride 
gradient. Fraction numbers and sodium chloride conentrations are indicated. (D) Reactions were 
preformed in the presence of various detergents as indicated. P, probe only. 
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3.2.5 The Minimal Binding Site of YY1 Contains Eleven Nucleotides – To 
determine the minimal binding site of YY1, single-stranded U20 RNA was partially digested with 
RNase A, generating a population of probe fragments ranging in length from 1 to 20 nucleotides.  
Binding reactions were assembled with digested probe mixture and recombinant YY1 in the 
presence of nickel-charged NTA-agarose resin.  YY1-RNA complexes formed in solution were 
recovered by binding of YY1 to the affinity matrix via the N-terminal His tag.  The smallest 
fragment retained corresponds to the minimal binding site of YY1.  Sequencing gel analysis of 
bound probe revealed YY1 bound fragments of 11 nucleotides and larger (Figure 12).   Probe 
was not retained in control reactions without YY1 (data not shown).  A minimum of 11 
consecutive nucleotides are therefore required for binding of YY1 to RNA, and the YY1-RNA 
complexes observed with 20-mer probes (Figure 10) likely contain a single YY1 molecule. 
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Figure 12
  
 - Determination of YY1 Minimal Binding Site. Poly-U(20) RNA probe (5 pmol) 
was partially digested with RNase A and added to RNA-binding reactions with 0.2 nmol YY1 in 
the presence of nickel-charged NTA-agarose, and sequencing gel analysis of bound poly-U RNA 
fragments was performed. Fragment sizes are indicated at left. nt, nucleotides; P, unbound probe; 
B, bound probe. 
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3.3 YY1 RNA-Binding Activity is Required for Assembly of YY1 into mRNPs – 
Results obtained with recombinant protein described above were confirmed using native 
preparations of the endogenous protein isolated from oocyte mRNPs.  Complexes isolated by 
oligo-dT cellulose chromatography (Ficzycz et al., 2001) were eluted and renatured, yielding an 
active preparation of isolated mRNP proteins, including YY1 (Figure 13A).  Control analysis of 
one oocyte equivalent of this preparation by EMSA using YY1 DNA consensus probe revealed 
the presence of DNA binding activity (Figure 13B).  YY1-DNA complexes were competed by 
specific oligonucleotide competitor or anti-YY1 antibody but were not affected by nonspecific 
competitors.  Next, one oocyte equivalent of the mRNP preparation was analyzed for binding to 
U20 RNA probe.  Two prominent retarded bands were observed that were competed specifically 
by A:U RNA duplex, YY1 consensus DNA, or anti-YY1 antibody (Figure 13B).  Addition of 
G:C, for which recombinant YY1 displayed low affinity (Figure 10), did not compete for 
complex formation.  Addition of YY1 mutant consensus DNA element or anti-PCNA antibodies 
also did not reduce complex formation.  The results of nucleic acid binding experiments were 
consistent between both recombinant and native mRNP-associated YY1, with the exception that 
native YY1 formed two retarded bands.  It is possible that other mRNP proteins, isolated by 
oligo-dT chromatography, are present in the retarded complexes.  Together, these data clearly 
demonstrate that YY1 isolated from oocytes has the capacity to bind RNA directly and with high 
affinities similar to that for the DNA consensus. 
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Figure 13
  
 - RNA-Binding Characteristics of Endogenous mRNP-Associated YY1. (A) 
mRNPs were obtained from stage VI oocytes by oligo-dT cellulose chromatography. Oocyte 
extract loaded onto oligo-dT matrix (LO), unbound material in flow-through (FT), and 
formamide eluant (EL) were analyzed by SDS-PAGE and silver staining (top panel) or Western 
blotting (lower panels). Position of molecular mass markers (top panel) and antibodies used 
(lower panels) are indicated at left. For both silver staining and western blotting, volumes were 
adjusted such that each lane contained one oocyte equivalent of material. (B) YY1-containing 
mRNP eluant was renatured and subjected to EMSA with 10 nM consensus DNA probe (upper 
panel). DNA-binding reactions contained one oocyte equivalent of material. Competitor DNAs 
(1 pmol) and antibodies (200 ng) added to binding reactions are indicated above the panel. The 
position of the YY1/DNA complex is indicated at left. RNA-EMSA (lower panel) was 
performed with renatured mRNP samples and 10 nM poly-U(20) RNA probe. The position of 
YY1/RNA complexes are indicated at left. The RNA (1 pmol), DNA (1 pmol), and antibody 
(200 ng) competitors added to reactions are indicated at the top of the panel. P, probe only; L, 
crude lysate; E, eluant.  
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To demonstrate YY1 can associate directly with maternal mRNAs, in vitro binding 
reactions were assembled containing poly-A+ mRNA isolated directly from oocytes and 
recombinant YY1.  Following incubation, reactions were subjected to oligo-dT cellulose 
chromatography to test for protein interaction with the maternal mRNA pool.  Retention of YY1 
on oligo-dT matrix demonstrated that YY1 was able to associate directly with maternal mRNA 
(Figure 14A).  Treatment of reactions with RNase A abolished recovery of YY1 in bound 
fractions.  The formation of YY1-mRNA complexes was effectively blocked by addition of U20 
to binding reactions but not by C20, results that are consistent with the direct RNA-binding 
experiments shown in Figure 10 and Table 2.  Addition of U20 to reactions at the concentrations 
indicated did not significantly reduce total recovery of mRNA/mRNPs in bound fractions (data 
not shown).  These in vitro data demonstrate that YY1 is able to bind directly to native maternal 
mRNA in the absence of other mRNP constituents. 
The process of YY1-mRNP assembly was investigated in vivo by expression of HA-
tagged YY1 from a plasmid construct (pHA3-YY1) microinjected into oocytes, and subsequent 
examination of cytoplasmic extracts by size exclusion chromatography (SEC) and oligo-dT 
cellulose chromatography (Figure 14B and 14C).  The results show that nascent HA-YY1 
assembled into poly-A+ mRNPs with a mean molecular mass of 480 kDa, identical in size to 
native YY1-containing mRNPs (Figure 14B) (Ficzycz et al., 2001).  Additionally, HA-YY1 was 
retained on oligo-dT cellulose via interaction with maternally-derived endogenous poly-A+ 
mRNAs in vivo (Figure 14C).  Cytoplasmic microinjection of RNase A into HA-YY1 expressing 
oocytes abolished retention of HA-YY1 on the oligo-dT matrix, demonstrating that isolation of 
HA-YY1 by oligo-dT cellulose is dependent on intact mRNA and is not due to anomalous 
interaction between oligo-dT and recombinant protein. 
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Time course experiments revealed HA-YY1 could be detected in mRNPs as early as 2 h 
after microinjection with peak levels of mRNP-associated HA-YY1 appearing after 12 h (data 
not shown).  This indicates that the molecular machinery responsible for the assembly of mRNPs 
is completely functional in the mature oocyte and that epitope-tagged YY1 is competent to 
assemble into mRNPs.  In some experiments, oocytes were enucleated after 8 h of expression, 
and nuclear and cytoplasmic extracts were analyzed by Western blot.  HA-YY1 was found to be 
completely localized to the cytoplasm (data not shown), identical to what has been observed for 
native YY1 (Ficzycz et al., 2001; Ficzycz and Ovsenek, 2002).  The assembly of HA-YY1 into 
mRNPs was significantly and specifically reduced by cytoplasmic microinjection of competitor 
RNA (U20) (Figure 14C).  Microinjection of RNAs for which YY1 displayed low affinity in vitro 
did not affect assembly of HA-YY1-mRNPs.  The observation that high affinity RNA substrates 
are able to inhibit YY1-mRNP assembly in vivo clearly demonstrates that the RNA binding 
activity of YY1 is not only biologically relevant but is an absolute requirement for its assembly 
into mRNP complexes.  These observations also show that protein-protein interactions between 
YY1 and other mRNP proteins are not sufficient for association with mRNPs, and that the most 
dominant process in YY1-mRNP association is direct interaction with maternal mRNA.  
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Figure 14
  
 - Binding of YY1 to mRNA in vitro and in vivo. (A) In vitro binding reactions 
containing 10 pmol of recombinant YY1 and 0.5 µg of poly(A+) mRNA isolated from oocytes 
were subjected to oligo-dT cellulose chromatography. Bound (B) and unbound (U) fractions 
were analyzed by Western blotting for YY1. Some reactions were treated with 1 µg pf RNase A 
or 20 pmol of poly-U(20) or poly-C(20) competitors as indicated. Con, control. (B) Lysates from 
HA-YY1 expressing oocytes (upper panel) and control oocytes (lower panel) were subjected to 
size exclusion chromatography and fractions analyzed by western blotting. Anti-HA antibody 
was used in the upper panel and anti-YY1 antibody was used in the lower panel. Position of 
fractions and molecular mass standard (MMS) are indicated above the panel. (C) Lysates from 
HA-YY1 expressing oocytes were subjected to oligo-dT cellulose chromatography and bound 
and unbound samples analyzed by Western blotting with anti-HA antibody. HA-YY1 expressing 
oocytes were sham injected (Con) or microinjected with 20 ng RNase A (RNase), 5 pmol of 
poly-U(20) RNA (+rU), or poly-C(20) (+rC) RNA 4 h prior to preparation of extracts. 
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3.4 A Subset of Oocyte mRNAs Associate with YY1 in Cytoplasmic mRNPs - In 
order to determine the subset of oocyte mRNA bound by YY1, an RNA-
immunoprecipitation/DNA microarray (RIP-CHIP) approach was used.  In this approach, oocyte 
lysates are prepared under conditions that preserve the integrity of mRNPs.  This lysate is then 
used in immunoprecipitation reactions with anti-YY1 antibody.  This allows isolation of mRNP-
YY1 along with the associated mRNAs.  The isolated mRNA was amplified by two rounds of 
reverse transcription followed by in vitro transcription.  The cRNA (copy RNA) was labelled by 
including biotin-UTP in the last in vitro transcription step.  Total oocyte RNA was isolated and 
labelled in a single round of reverse transcription followed by in vitro transcription in the 
presence of labelled UTP.  By hybridization of the labelled cRNA to a Xenopus laevis whole-
genome DNA microarray it was possible to determine the subset of mRNAs present in both total 
oocyte and in YY1-IP samples.  It is assumed that only mRNAs bound to YY1 and therefore 
isolated during anti-YY1 immunoprecipitation would be detected on the microarray hybridized 
with YY1-IP RNA.  This assumption was then verified by Real-Time PCR of reverse transcribed 
mRNA isolated by anti-YY1 immunoprecipitation.  The procedure for immunoprecipitation and 
labelling of YY1-associated mRNA is outlined in the flowchart shown in Figure 15. 
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Figure 15
  
 – Flowchart of RIP-CHIP Analysis of YY1 Associated mRNA. The procedure used 
for RNA immunoprecipitation – DNA microarray (RIP-CHIP) analysis of YY1 associated 
mRNA is shown diagramatically. Polyadenylated transcripts associated with YY1 are isolated by 
immunoprecipitation, reverse transcribed using a T7-oligo-dT primer, and double-stranded 
cDNA is produced by treatment with E. coli DNA polymerase I.  The resulting cDNA is 
transcribed in vitro using T7 polymerase and the resulting copy RNA (cRNA) is again reverse 
transcribed using random hexamers.  The second-round cDNA is again transcribed in vitro using 
T7 polymerase in the presence of biotin-UTP generating biotinylated cRNA which is 
subsequently used in hybridization to the microarray.  The procedure provides substantial 
amplification of mRNAs isolated by immunoprecipitation of YY1.   Astrisks indicate RNA, 
cDNA, or cRNA strands with identical sequences.   
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3.4.1 Isolation of YY1-mRNPs by Immunoprecipitation – To demonstrate 
that YY1-mRNPs could be isolated by immunoprecipitation with anti-YY1 antibody, 
immunoprecipitations were performed using lysates from oocytes expressing HA-YY1.  
Detection of endogenous YY1 by Western blotting of anti-YY1 immunoprecipitates is 
complicated by detection of the immunoprecipitating antibody heavy chain in the same vicinity 
as YY1 protein.  Therefore, since HA-YY1 has been shown to associate with mRNPs when 
expressed in oocytes (Section 3.3, Figure 14, and Figure 16) the utility of anti-YY1 antibody in 
isolation of YY1-mRNPs was examined by performing immunoprecipitations on lysates from 
HA-YY1 expressing oocytes.  Figure 16 demonstrates that anti-YY1 antibody is capable of 
immunoprecipitating HA-YY1 from lysates (Figure 16A).  Given that all expressed HA-YY1 
was associated with mRNA as determined by oligo-dT cellulose chromatography (Figure 16B), 
these data support the claim that anti-YY1 antibody is effective for immunoprecipitation of 
mRNP-associated YY1. 
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Figure 16
  
 – Suitability of Anti-YY1 Antibody for Immunoprecipitation of YY1. To verify 
the ability of anti-YY1 antibody to immunoprecipitate YY1 from oocyte lysates, 
immunoprecipitations were performed on lysates from HA-YY1 expressing oocytes. Expression 
of HA-YY1 in oocytes was achieved by nuclear injection of 20 ng pHA3-YY1. After allowing 
18 h for expression of tagged YY1, oocytes were lysed and the properties of HA-YY1 analyzed 
by immonoprecipitation with anti-YY1 antibody and oligo-dT cellulose chromatography. (A) 
HA-YY1 expressing oocyte lysates (L) were subjected to immunoprecipitation using anti-IκB 
(α κΙB), anti-YY1 (αYY1), or with protein-A sepharose beads alone (-) and bound material was 
analyzed by Western blotting with anti-HA antibody. Position of HA-YY1 band in is indicated at 
left. (B) Lysates (LO) from HA-YY1 expressing oocytes were prepared in the presence of RNase 
inhibitor or supplimented with RNase A (+R) and applied to olgio-dT cellulose matrix. Unbound 
flow through (FT) and bound material eluted with formamide (EL) was analyzed by Western 
blotting with anti-HA antibody. Position of HA-YY1 band in is indicated at left.  
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 3.4.2 RIP-CHIP analysis of YY1-mRNPs – Previously, the subset of oocyte 
mRNAs present in YY1-containing mRNPs was unknown.  To address this issue, YY1 
containing mRNPs and the mRNAs contained in them were isolated by immunoprecipitation 
with anti-YY1 antibody.  The isolated mRNA was amplified, labelled, and used to probe a 
Xenopus laevis oligonucleotide microarray, an approach termed RIP-CHIP analysis.  This 
approach allowed simultaneous identification of thousands of transcripts associated with YY1 in 
mRNPs.  Bioinformatic and biochemical analysis of the functional roles of these transcripts is 
expected to provide considerable insight into the biological function of YY1 in mRNPs, and the 
functions of mRNPs in development.  This analysis required comparison of the subset of 
transcripts present in YY1-mRNPs to the total set of transcripts expressed in the oocyte.  
Total oocyte mRNA from five separate females and YY1 IP RNA from three 
separate females was analyzed using the Xenopus laevis Genome 2.0 oligonucleotide microarray 
(Affymetrix) and data from replicate samples was averaged.  The datasets thus produced were 
used to generate the scatter plot shown in Figure 17.  Messenger RNAs with similar levels in 
total oocyte RNA and YY1 IP RNA lie along a diagonal of slope = 1. Figure 17 shows a number 
of data points to the lower right of this line representing mRNAs with abundances higher in YY1 
IP RNA relative to total RNA as well as a number of data points to the upper left of this line 
representing mRNAs with abundances lower in YY1 IP RNA relative to total RNA.  The further 
toward the lower right a data point appears in the scatter plot the greater the likelihood the 
corresponding mRNA is present in YY1-containing mRNPs.  Conversely, the further to the upper 
left a data point appears in the scatter plot the less likely it is that the corresponding mRNA is 
present in YY1-containing mRNPs.  In the present work, only those data points that deviate 
substantially from the isometric diagonal were considered (the rationale for this approach is 
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discussed more fully in section 4.3).    Messenger RNAs with a mean log(signal intensity) > 3 in 
total RNA  and > 3.17 in YY1 IP RNA were considered likely to be present in YY1-mRNPs 
while mRNAs with mean log(signal intensity) > 3 in total RNA and < 2.7 in the YY1 IP RNA 
were considered unlikely to be present in YY1-mRNPs.  Treatment of the data in this fashion 
resulted in identification of 1147 mRNAs present in YY1-mRNPs and 396 mRNAs not present 
in YY1-mRNPs.  Of 1147 mRNAs identified as present in YY1-mRNPs, 730 (~63%) were 
unannotated transcripts while 417 (~37%) were known, characterized gene products.  Among the 
396 mRNAs identified as not present in YY1-mRNPs, 277 (~70%) were unannotated transcripts 
while 119 (~30%) were known, characterized gene products.  The characterized transcripts 
identified in YY1-mRNPs are listed in Table 3 while characterized transcripts identified as not 
present in YY1-mRNPs are listed in Table 4. 
In order to determine if transcripts present inYY1-mRNPs were associated with 
specific cellular functions, sequences were compared with the Mus musculus nucleotide database 
in order to retrieve Gene Ontology terms for transcripts with characterized protein products.  
Each transcript was categorized according to the retrieved Gene Ontology terms by molecular 
function (Table 5), cellular component (Table 6), and biological process (Table 7).  Altogether, 
the functions associated with the protein products of YY1-bound transcripts were extremely 
diverse.  Major molecular functions of YY1-associated transcript products (Table 5) were 
protein- and ATP-binding, reflecting the large number of regulatory protein transcripts (Table 3), 
and DNA-binding, reflecting the large number of transcripts encoding transcription factors.  Also 
significant were transcripts encoding RNA-binding factors and zinc-binding proteins.  
Categorization of transcripts according to cellular component (Table 6) revealed the majority are 
nuclear proteins, with other major sites of residence being the cytoplasm, cell membrane, and 
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mitochondrion.  Major biological processes associated with YY1-bound transcripts (Table 7) 
were transcription and regulation of transcription, again reflective of the large number of 
transcription factor transcripts; and also mitosis and cell division, indicative of a large number of 
transcripts for Cyclin proteins and other cell-cycle regulators (see Table 3).  Altogether the 
results of Gene Ontology analysis shows the protein products of transcripts in YY1-mRNPs are 
associated with a very diverse set of cellular functions, however, major roles for these proteins 
are transcriptional regulation, cell cycle control, and signalling.  These data are consistent with 
the hypothesis that maternally derived oocyte mRNAs present in YY1-mRNPs are utilized 
selectively during later development where their protein products direct important processes in 
growth and differentiation.       
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Figure 17
  
 - RIP-CHIP Analysis of Total mRNA and YY1 IP mRNA.  A histogram was 
generated from mean signal intensity for each probe set (spot) on a Xenopus 2.0 Whole-Genome 
microarray probed with total oocyte RNA (Y-axis) plotted against mean signal intensity for each 
probe set in an identical array probed with anti-YY1 IP RNA.  Control data comprises five 
independent replicates while anti-YY1 RNA data is derived from three independent replicates.  
Spots located toward the upper left of the diagram indicate mRNA which were not likely present 
in YY1-mRNPs while spots located further toward the bottom right indicate mRNAs which were 
highly enriched in anti-YY1 immunoprecipitates and are therefore likely present in YY1-
mRNPs.  
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Figure 18 - Comparison of Levels of Selected mRNAs in anti-YY1 IP and Total mRNA.  
Data from anti-YY1 RIP-CHIP analysis was compared with data obtained from DNA microarray 
analysis of total oocyte mRNA and used to select five mRNAs with high signal levels in both 
control and anti-YY1 IP (shown in A); and five mRNAs with high signal levels in control and 
low signal levels in anti-YY1 IP (shown in B). The average signal level of each mRNA in 
control RNA is shown in dark grey and the average signal level for each mRNA in anti-YY1 IP 
RNA is shown in light grey. mRNAs are identified on the x-axis, mean signal intensity is shown 
on the y-axis. Error bars indicate standard deviation. 
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 3.4.3 Ver ification of RIP-CHIP analysis by Real-Time PCR – Real-Time PCR 
was used to verify the accuracy of the RIP-CHIP analysis.  Ten mRNAs predicted by RIP-CHIP 
to be either present or absent in YY1-mRNPs were examined for their relative abundance in 
YY1-immunoprecipitates versus total oocyte RNA.  Average signal levels of these mRNAs in 
microarrays probed with total RNA and those probed with anti-YY1 IP RNA are shown in Figure 
18.  Real-Time PCR analysis reactions were conducted on three independently isolated sample 
replicates of total RNA and YY1 IP RNA. Using the method of Pfaffl et al. (Pfaffl, 2001) levels 
of the selected mRNAs in total oocyte mRNA was set to unity and the average level of the same 
mRNA in immunoprecipitated samples is expressed in Figure 19 as a fold increase or decrease.  
Overall, levels of these mRNAs as measured by Real-Time PCR corresponded well with the 
relative levels obtained by microarray analysis.  For example, XNop56, a transcript associated 
with YY1 in RIP-CHIP was found to be approximately ten times more abundant in YY1-IP RNA 
versus total oocyte RNA while RPL3, suggested by RIP-CHIP not to associate with YY1 in 
mRNPs, was only 10 % as abundant in YY1-IP RNA as in total oocyte RNA as assessed by Real-
Time PCR (Figure 19).  These data substantiate that levels of RNA determined by RIP-CHIP are 
accurate reflections of actual RNA levels in the samples analyzed.  Taken together with the data 
presented in section 3.4.1, this substantiates the utility of microarray analysis of YY1 
immunoprecipitates for determining the mRNA content of YY1-containg mRNPs. 
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Figure 19 - Verification of Gene Chip Results by RT-PCR Analysis of Selected mRNAs.  
Levels of selected mRNAs (bottom of panels) were analyzed by quantitative real-time PCR.  
Values shown are averages of three independent replicate experiments and are displayed relative 
to the level of the same mRNA in total mRNA.  The upper panel (A) shows mRNAs predicted by 
microarray analysis to be highly enriched in anti-YY1 immunoprecipitates while the lower panel 
(B) shows mRNAs predicted by microarray analysis to be highly depleted or absent in anti-YY1 
immunoprecipitates.  Error bars indicate standard error.   
 125 
 
 
 126 
 
3.5 YY1 RNA-Binding Activity is Present in the Cytoplasm of Cultured Cells – 
The data presented thus far show that Xenopus YY1 possesses high-affinity, substrate-specific 
RNA binding activity, and that its RNA-binding activity is required for association of the protein 
with mRNP complexes in vivo.  Furthermore, DNA microarray analysis demonstrates that YY1 
associates with a subset of the mRNAs present in the oocyte.  A number of studies have 
documented the presence of YY1 in the cytoplasm of adult tissue and culture cells in a variety of 
model systems (Donohoe et al., 1999; Favot et al., 2005; Krippner-Heidenreich et al., 2005; 
Palko et al., 2004; Rylski et al., 2008), suggesting that YY1 could play a role in mRNA storage 
in somatic cells.  Given the RNA-binding activity of YY1 described here for the first time, it was 
desirable to perform a comparative analysis of Xenopus and Human culture cells, to determine if 
Human YY1 possesses RNA-binding activity similar to YY1 isolated from oocyte mRNPs.  
Xenopus A6 kidney epithelial cells and Human HepG2 hepatocarcinoma cells were grown in 
culture and fractionated into nuclear and cytoplasmic extracts.  Analysis of these extracts by 
Western blotting shows that Xenopus YY1 protein is present at high levels in the cytoplasm and 
at moderate levels in the nucleus of A6 cells (Figure 20A).  Analysis of HepG2 cells showed the 
majority of cellular Human YY1 was present in the nuclear fraction with a moderate amount of 
YY1 present in the cytoplasm (Figure 20A).  Western blotting controls with the nuclear protein 
PCNA showed these findings were not attributable to nuclear contamination of cytoplasmic 
extracts.  EMSA analysis shows that YY1 DNA-binding activity was detectable in both nuclear 
and cytoplasmic fractions of both A6 and HepG2 cells at levels proportional to the quantities of 
YY1 protein detected in these cellular compartments by Western blotting (Figure 20A).  Next, 
the cytoplasmic fractions of A6 and HepG2 cells were analyzed by EMSA using U20 RNA 
probe.  A specific YY1-RNA band was detected in both A6 and HepG2 cytoplasmic extracts.  
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The shifted complex was competed specifically by unlabelled YY1 consensus DNA element but 
not by mutated consensus DNA (Figure 20B).  These data are the first demonstrations of specific 
YY1-RNA binding activity in the cytoplasm of culture cells, suggesting the ability of YY1 to 
bind RNA is not restricted to oocytes and early embryos (Ficzycz et al., 2001).  Furthermore, the 
detection of specific YY1 RNA-binding activity in HepG2 cells constitutes the first 
demonstration of RNA-binding activity by the Human YY1 protein.  
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Figure 20
  
 - Nucleocytoplasmic Distribution of YY1 in Cultured Cells and Analysis of 
Cytoplasmic YY1 DNA- and RNA-Binding Activity. (A) Nucleocytoplasmic distribution of 
YY1 was analyzed in Xenopus A6 kidney epithelial cells (A6) and in human hepatocellular 
carcinoma (HepG2) cells by Western blotting (upper two panels) using 10 µg protein per lane. 
Antibodies used (indicated at left) were anti-YY1 (YY1) and anti-PCNA (PCNA). Presence of 
YY1 in the cytoplasm was confirmed by DNA EMSA (lower panel) using 10 µg protein per 
reaction and 10 nM YY1-consensus DNA probe . The position of the YY1/DNA complex is 
indicated at left. W, whole cell extract; N, nuclear extract; C, cytoplasmic extract. (B) 
Cytoplasmic YY1 RNA-binding activity in A6 and HepG2 culture cells was analyzed by EMSA 
using 20 µg cytoplasmic protein and 10 nM radiolabelled poly-U(20) RNA probe. The position 
of the YY1/RNA complex is indicated at left. Specificity of the detected band was confirmed by 
addition of 1 pmol competitor as indicated above the panel. P, probe alone; CL, cytoplasmic 
lysate; YY1E, double stranded YY1 consensus DNA; YY1M, double stranded YY1 mutant 
DNA; P, probe alone  
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4. Discussion - The major conclusion of this thesis is that YY1 associates with a subset of 
maternally transcribed mRNAs via direct RNA-binding activity.  Recombinant YY1 was 
expressed in bacteria and conditions for its efficient isolation and renaturation were empirically 
determined.  The activity of recombinant YY1 was shown to be sensitive to oxidation and the 
presence of nickel ions.  Use of reducing agents during isolation of YY1 and treatment of YY1 
with EDTA following IMAC purification were required to achieve full activity of the 
recombinant protein.  YY1 was found to have a magnesium- and zinc-dependent RNA-binding 
activity with some sequence specificity toward U-rich sequences, and a minimal requirement of 
11 consecutive nucleotides for RNA-binding.  This novel biochemical activity of YY1, described 
here and in a recent Journal of Biological Chemistry article for the first time (Belak and 
Ovsenek, 2007), was shown to be required for association of YY1 with mRNPs in Xenopus 
oocytes.  Additionally, YY1-RNA interactions were highly stable.  RNA-
immunoprecipitation/DNA microarray (RIP-CHIP) analysis was used to analyze the population 
of oocyte mRNAs associated with YY1 in mRNPs.  It was shown that YY1 associates with a 
highly varied population of mRNAs that appear to be utilized later in development.  There were a 
number of maternal transcripts that were not detected in the YY1-mRNP pool, encoding proteins 
such as Vitellogenin Receptor, Zona Pellucida Glycoprotein Homologue, and oocyte-specific 
Elongation Factor-1α isoform known to be translated specifically in the oocyte.  In addition, 
transcripts from the mitochondrial genome were not detected in the YY1-mRNP pool, a finding 
consistent with the efficacy and fidelity of the RIP-CHIP methodology.  Of all known mRNP 
constituent proteins, YY1 is the first for which the in vivo mRNA substrates have been 
determined.  Finally, YY1 protein was shown through biochemical assays to be present in the 
cytoplasm of both Xenopus and human culture cells, and a specific YY1 RNA-binding activity 
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was detected in adult cells of human and Xenopus origin. Taken together, these data offer 
considerable support for a biological role for YY1 outside transcriptional regulation, and provide 
some insight into the general structure of mRNPs. 
4.1 Pur ification and Renaturation of Recombinant YY1 – Immobilized metal 
affinity chromatography is widely used for the production of recombinant proteins for a variety 
of applications.  Basic IMAC protocols are often sufficient for production of recombinant 
proteins either because subsequent applications do not require high specific activity or target 
proteins assume their native conformations under standard conditions (Porath, 1992).  In the case 
of YY1, however, there was a requirement for extensive optimization of the IMAC procedure to 
achieve high specific activities.  For applications such as analysis of protein-nucleic acid binding 
affinities it is especially important to pay close attention to the conditions utilized in production 
of the recombinant protein in question (Block et al., 2009).  A disciplined approach to the design 
of IMAC protocols therefore ensures the integrity and accuracy of in vitro experimentation 
aimed at determining specific protein activities, in this case, the RNA-binding activity of YY1.  
To this end it was necessary that the conditions used in the preparation of recombinant YY1 
resulted in a product that was highly purified, is in the native conformation, and free of 
contaminants that could interfere with or inhibit protein activity.  In general IMAC applications, 
the effects of protein oxidation and the presence of residual metal ions from immobilized metal 
affinity chromatography are often overlooked (Belew et al., 1987; Block et al., 2009; Chaga, 
2001; Esfandiar et al., 2010; Gaberc-Porekar and Menart, 2001; Porath, 1992; Zhu et al., 2005).  
Careful control and analysis of the procedures and reagents used in production of recombinant 
YY1 used in this study resulted in greater reproducibility, higher specific activities, and results 
which more accurately reflected protein activities in vivo (Block et al., 2009; Chaga, 2001; 
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Gaberc-Porekar and Menart, 2001; Porath, 1992; Smith et al., 1988).   
Here, the parameters of protein purification using IMAC are discussed in some detail.  
A suitable lysis buffer has three characteristics: It must efficiently lyse the bacterial cells, it must 
provide an environment in which the target protein is soluble and stable, and finally, must be 
compatible with subsequent chromatography steps.  Initial work therefore focused on comparing 
the effectiveness of different lysis methods for preparation of YY1, involving comparison of 
buffers with lysozyme and various denaturants.  Lysozyme is a standard reagent used to degrade 
the cell wall of E. coli and facilitate lysis of bacterial cells for isolation of recombinant proteins 
(Birdsell and Cota-Robles, 1967; Block et al., 2009; Zinder and Arndt, 1956).  Lysozyme is 
active in buffers which are iso-osmotic with respect to bacterial cells (Birdsell and Cota-Robles, 
1967; Dickman and Proctor, 1952), therefore, utilizing lysozyme offers the advantage of 
isolation of proteins under native or near-native conditions, which would facilitate analysis of 
YY1.  One disadvantage of lysozyme is diminished protein activity under reducing conditions 
(Abraham, 1939; Dickman and Proctor, 1952; Jolles and Jauregui-Aolles, 1963).  Given the 
sensitivity of YY1 to oxidation shown in Figures 2B and 4C, the inclusion of reducing agents is 
desirable, but precludes the use of lysozyme.  Furthermore, Figure 2A demonstrates that when 
bacterial cells expressing YY1 were subjected to lysis by lysozyme, little of the YY1 protein was 
present in the soluble fraction.  Since the activity of the lysozyme preparation used in this work 
was verified, it is concluded that formation of YY1 inclusion bodies in bacterial cells is the most 
likely explanation for low YY1 solubility in non-denaturing lysis buffers (Razeghifard, 2004). 
Generally, eukaryotic proteins are not folded efficiently into their native 
conformations in prokaryotic expression systems causing eukaryotic proteins isolated after 
prokaryotic expression to exhibit low specific activity relative to these proteins in their 
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endogenous cellular environments (Chang et al., 2005).  Therefore it is often preferable to isolate 
recombinant proteins in the presence of strong denaturing agents and to subsequently renature 
them.  Guanidium offers the advantage over urea of higher solubility at lower temperatures, 
allowing protein isolation to be performed at low temperature (4 °C), however, the disadvantage 
of insoluble complex formation with SDS necessitates its removal from recombinant proteins 
prior to SDS-PAGE analysis.  This introduces the cumbersome additional step of ethanol 
precipitation (guanidium hydrochloride is insoluble in acetone), which reduces the ease of 
sample analysis, and is eliminated by the effectiveness of 8 M urea in solubilising recombinant 
YY1 (Figure 2).  The main drawback of urea for protein purification by IMAC protocols is 
reduced solubility at the lower temperatures frequently used in IMAC steps.  This problem was 
overcome in two ways: First, after lysis, buffers were diluted to 4 M urea prior to 
chromatography, so that variations in ambient temperature down to ~10 °C were tolerable. 
Second, YY1 was stable for at least 72 h at temperatures up to 37 °C in buffers containing 4 M 
urea and 1 mM 2-mercaptoethanol (Figure 2B).  In conclusion, lysis buffers containing 8 M urea 
are ideal for YY1 isolation due to effective lysis of bacterial cells, solubilisation of recombinant 
protein, and compatibility with added reducing agents and subsequent IMAC steps. 
It was shown in Figures 2B and 4C that YY1 is sensitive to oxidation.  Formation of 
both intermolecular and intramolecular disulfide bonds in YY1 would reduce specific activity of 
the purified protein, therefore use of reducing conditions in all protein isolation steps is 
advisable.  This is particularly relevant when experiments measuring binding affinities of 
recombinant proteins are undertaken since protein preparations with abnormally low specific 
activities would yield inaccurate affinity values.   
The selection of reducing agent is influenced by several factors.  Dithiothreitol (DTT) 
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is commonly used at concentrations of 1 mM to prevent protein oxidation in solution, however it 
is unstable in aqueous solutions at pH exceeding 7.0 at temperatures above freezing (Getz et al., 
1999) making it particularly inappropriate for inclusion in wash and elution buffers stored at 
room temperature.  Due to its ready availability and stability in aqueous solution, 2-
mercaptoethanol was used to maintain reducing conditions in lysis, wash, elution, and 
renaturation buffers.  The data in Figure 2B and 4C show that 2-mercaptoethanol at 
concentrations of 1 mM effectively prevented oxidative aggregation of proteins in lysates.  The 
relatively new reducing agent tris(2-carboxyethyl)phosphine (TCEP) was not evaluated in this 
study.  TCEP has a number of potential advantages such as stability in aqueous solution and non-
volatility (Getz et al., 1999).  TCEP does not complex or reduce nickel ions bound to NTA-
agarose and so is compatible with IMAC resins (Bergendahl et al., 2002).  Given the higher cost 
of TCEP and the demonstrated effectiveness of 2-mercaptoethanol, it is concluded that 2-
mercaptoethanol is satisfactory for the current application. 
There have been a number of reports of efficient on-column renaturation of various 
recombinant proteins using IMAC  (Esfandiar et al., 2010; Li et al., 2004; Liu et al., 2007; 
Razeghifard, 2004; Zhu et al., 2005).  The concept of on-column renaturation is intriguing and 
should be considered in many applications due the simplicity of direct elution of active protein.  
In the present example, columns with bound YY1 were washed and eluted under conditions that 
would presumably favour renaturation and acquisition of activity.  However, this simple 
procedure resulted in suboptimal YY1 nucleic acid binding activity even after extensive removal 
of imidazole.   
It was found that residual nickel ions from IMAC chromatography had a strong 
inhibitory effect on YY1 nucleic acid binding activity (Figure 4C).  For these reasons, it was 
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necessary to supplement eluted YY1 with guanidium isothiocyanate and EDTA and to perform 
renaturation by exchange into buffers containing zinc and magnesium.  The data in Figure 4A 
and B show that YY1 was renatured effectively using these conditions.   Collectively, the data 
demonstrate the importance of both redox and metal ion effects in the preparation of the 
recombinant YY1 used in this study for in vitro analyses.  
4.2 RNA-Binding Activity of YY1 - Bacterially expressed, highly purified, 
recombinant YY1 was used for in vitro analysis of RNA-binding activity with a variety of probes 
(Figures 6 - 10), and the results were confirmed using endogenous YY1 isolated from oocyte 
mRNPs (Figure 13).  These findings confirm the mechanism by which cytoplasmic YY1 
associates with maternally derived mRNA molecules in mRNP complexes is through direct RNA 
binding activity.  The major conclusions arising from this data are that YY1 has sequence 
specific RNA-binding activity for U-rich single stranded and A:U duplex RNA; and that YY1 
does not appear to associate with RNA ends, but with internal regions of maternal transcript 
(Figures 8 – 10). 
YY1 displayed highest affinity for single stranded poly-U RNA (Table 2), on the same 
order of affinity as for its DNA consensus site (Houbaviy and Burley, 2001; Houbaviy et al., 
1996; Momoeda et al., 1995).  YY1 displayed sequence specificity in its RNA-binding 
characteristics, with high affinity for A:U duplexes and single-stranded U-rich regions.  It is 
hypothesized that these sequences are likely targets of YY1 in mRNPs in vivo.  Binding to 
several single-stranded substrates other than U20 was also observed, however, intramolecular A, 
G, or C residues significantly reduced or abolished binding for U-rich regions in both single and 
double stranded substrates (Figure 10, Table 2).  Low affinity binding was observed for several 
substrates, with affinities substantially lower than for the DNA consensus (Figure 10, Table 2).  
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No affinity was observed for RNA sequences such as C20, (AC)10, or any of the duplexes with the 
exception of A:U.  Furthermore, very low affinity was observed for RNA probes containing YY1 
DNA consensus sequences (Figure 10).  It is therefore unlikely that the high-affinity RNA-
binding activities observed for U20 and A:U observed in this study is solely the result of non-
specific or backbone interactions between YY1 and these RNA probes.  The data taken together 
demonstrate sequence specificity in YY1 RNA binding.  It therefore appears that YY1 recognizes 
internal regions of mRNAs, perhaps at U-rich or A:U-rich duplex regions within mRNAs (Figure 
10).  This is supported by data showing YY1 did not bind to the 7-mGpppG 5’-cap structure 
(Figure 8, Table 2), or single stranded poly-A probes which would mimic the poly-A tail of 
maternal mRNAs (Figure 10, Table 2).   
A number of experiments showed that YY1-RNA interactions are highly stable (Figure 
11) which would be consistent with the hypothesized role for YY1 in long-term RNA storage 
through the protracted duration of oogenesis and into embryonic development.  High-affinity 
RNA binding activity of YY1 was observed at physiological temperatures, in >0.4 M sodium 
chloride, and in the presence of non-ionic detergents (Figure 11).  These data are consistent with 
endogenous YY1 exhibiting RNA-binding activity under the physiological conditions of the 
Xenopus oocyte and further support the hypothesis that the observed RNA-binding activity of 
YY1 is present in vivo and underlies the mechanism of association of YY1 with mRNPs.  Indeed, 
interaction of endogenous YY1 with mRNPs was destabilized at similar concentrations of 
sodium chloride as those that destabilized interaction of recombinant YY1 with RNA in vitro.  In 
any event, the high affinity observed in YY1-RNA interactions clearly implies a relevant 
biological activity, and could easily account for the presence of YY1 in mRNPs.  
The substrate specificity of YY1 strongly suggests that RNA recognition occurs by a 
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different mechanism than DNA recognition since YY1 displayed very low affinity for single- or 
double-stranded RNA oligonucleotides containing sequences homologous to the DNA-binding 
site.  Of all known zinc finger RNA-binding proteins, the precise mode of RNA-interaction has 
only been elucidated for three proteins.  These include the Xenopus C2H2 zinc finger proteins 
TFIIIA and ZFa, and the human CCCH zinc finger protein TS11d (Hall, 2005; Lu et al., 2003; 
Moller et al., 2005).  Whereas the mode of DNA recognition by zinc finger proteins invariably 
involves recognition helix/major groove interactions, the same general principles do not apply to 
RNA recognition (Brown, 2005).  The RNA-binding zinc fingers of TFIIIA make specific 
contacts with RNA bases in highly structured helical and non-helical regions, and it binds a 
double-stranded region of the 5S RNA with high sequence specificity (Hall, 2005).  ZFa, in 
contrast, binds double stranded RNA with little apparent sequence specificity, primarily through 
interaction with the RNA backbone (Moller et al., 2005).  YY1 displays less apparent RNA 
sequence specificity than TFIIIA but more than ZFa (Figure 10, Table 2).  YY1 displays high 
affinity for a single stranded substrate, implying divergence in the mode of RNA recognition 
between C2H2 proteins.  Interestingly, YY1 behaviour more closely resembles the CCCH zinc 
finger protein TS11d.  TS11d has high affinity for AU-rich duplex RNA and the solution 
structure of this protein in complex with RNA has been determined (Hall, 2005).  Sequence 
specificity of TS11d is apparently mediated entirely by peptide backbone contacts with Watson-
Crick base pairs in helical RNA.  Given the capacity of YY1 to bind single stranded substrates 
(poly-U) it would appear there is considerable variability in the mechanisms by which zinc finger 
proteins recognize RNA. 
The present study constitutes the most comprehensive analysis of the RNA-binding 
activity of any of the known Xenopus mRNP proteins.  Despite the absence of detailed structural 
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or affinity analyses, some of the general RNA-binding characteristics of Xp54, FRGY2a/b, and 
Rap55 have been established and previous work provides a context in which to consider the 
observed characteristics of YY1.  Xp54 is a double-stranded RNA-binding DEAD-box protein 
that displays ATP-dependent RNA-helicase activity when phosphorylated (Ladomery et al., 
1997; Minshall et al., 2001).  FRGY2A/B are cold shock domain proteins that associate with 
single-stranded regions of RNA (Marello et al., 1992).  Like YY1, FRGY2A/B possesses dual 
functional roles in transcriptional regulation and RNA-binding in mRNPs. Some reports indicate 
FRGY2A/B have sequence specificity toward RNA substrates with sequences similar to the 
FRGY2A/B DNA consensus site (Bouvet et al., 1995; Matsumoto et al., 1996).  This behaviour 
is in contrast to the findings with YY1, which did not show appreciable affinity for RNAs 
containing the DNA consensus site (Figure 9).  Rap55 possesses an RGG RNA-binding domain 
responsible for generalized, non-specific interaction with RNA; and there is some experimental 
evidence to suggest it plays a role in translational repression of bound transcripts (Lieb et al., 
1998; Marnef et al., 2009; Tanaka et al., 2006).  YY1, in comparison, is a multifunctional protein 
containing four C-terminal zinc fingers (Shi et al., 1997).  YY1 differs from other mRNP 
proteins in displaying significant RNA sequence specificity and its ability to associate with both 
single and double stranded RNA.  The functional consequences of these differences remain to be 
determined.   
The major mRNP proteins had previously been shown to be recruited to maternal mRNA 
molecules destined for long term storage in the oocyte (Ladomery et al., 1997; Matsumoto et al., 
1996; Moore, 2005; Yurkova and Murray, 1997), as is shown here to be true for YY1.  It is 
generally believed that these proteins are universal constituents of mRNPs with potential roles in 
translational regulation (Marello et al., 1992; Marnef et al., 2009; Matsumoto et al., 1996; 
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Minshall and Standart, 2004; Minshall et al., 2001; Tanaka et al., 2006; Yurkova and Murray, 
1997).   
The mechanisms by which mRNAs are selectively recruited from the mRNP pool for 
translation at the correct developmental stage have not yet been determined.  Therefore, the next 
logical step in this analysis was to identify mRNAs associated with YY1 in oocytes (see below).  
The major finding of the data presented in Figures 5 to 15, specifically that YY1 is able to 
associate directly with RNA and that this RNA-binding activity is the mechanism by which YY1 
is incorporated into mRNPs, is an important step toward determining its precise biochemical role 
in early development.  
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4.3 Procedural, Statistical, and Bioinformatic Considerations for RIP-CHIP 
Analysis of YY1-mRNPs - In order to determine the population of oocyte mRNA molecules 
bound by YY1, an RNA-immunoprecipitation/DNA microarray (RIP-CHIP) approach was used.  
In this approach, oocyte lysates were prepared under conditions that preserve the integrity of 
mRNPs.  This lysate is then used in immunoprecipitation reactions with anti-YY1 antibody.  This 
facilitated isolation of mRNP-YY1 along with the associated mRNAs.  The isolated mRNA was 
amplified by two rounds of reverse transcription followed by in vitro transcription.  The cRNA 
(copy RNA) was labelled by inclusion of biotin-UTP in the last in vitro transcription step.  Total 
oocyte RNA was isolated and labelled in a single round of reverse transcription followed by in 
vitro transcription in the presence of labelled UTP.  By hybridization of the labelled cRNA to a 
Xenopus laevis whole-genome DNA microarray it was possible to determine the subset of 
mRNAs present in both total oocyte and in YY1-IP samples.  The assumption regarding fidelity 
of this assay was that only mRNAs bound to YY1 would be isolated during anti-YY1 
immunoprecipitation and detected on the microarray hybridized with YY1-IP RNA.  This 
assumption was then verified by Real-Time PCR of reverse transcribed mRNA isolated by anti-
YY1 immunoprecipitation.  The working hypotheses were that YY1 would associate with a 
subset a subset of maternally transcribed mRNA molecules, and that therefore mRNPs are 
heterogeneous with respect to their mRNA content. 
This constitutes a novel application of DNA microarrays and as such, algorithmic 
methods for analysis of the resulting data currently do not exist.  A comprehensive discussion of 
the computer and statistical algorithms required for such analysis is out of the scope of the 
current work.  Therefore, a conservative initial categorical analysis was applied to the data:  
mRNAs with high signal intensities in total RNA samples that were substantially enriched in 
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YY1-IP RNA samples were presumed to be boundto YY1 in vivo while mRNAs which 
possessed high signal levels in total RNA samples but substantially lower signal values in YY1-
IP RNA samples were presumed not to be bound by YY1 in vivo.  This conservative analysis 
sharply reduced the chances of false positives but also likely resulted in false negatives; i.e. the 
elimination of many bona fide YY1 mRNA substrates from the list of transcripts associated with 
YY1.  This is due to the fact that mRNAs with low signal levels in total oocyte RNA and high 
signal levels in YY1-IP RNA would be classified as “not associated with YY1” even though this 
disparity almost certainly represents a significant enrichment of these mRNAs in YY1 IPs.  
However, in the absence of rigorous statistical analysis of the data it would not be possible to 
state with confidence that these mRNAs were in fact present in the total oocyte pool, and that 
their high signal level in anti-YY1 immunoprecipitates was not anomalous.   
As mentioned above, the potential existed for assignment of false positives.  The 
expected relative abundance for an unbound mRNA between total oocyte mRNA and 
immunoprecipitation reactions is approximately 10-6 (i.e. an unbound RNA with signal level 
100,000 in total RNA would be expected to have a signal level of 0.1 in IP material), however, 
the two step amplification procedure used could increase this to as much as 10-2.  Examination 
of the data presented in Table 3 reveals that among the top mRNAs classified as associating 
with YY1, virtually all were present at substantially higher levels in anti-YY1 IPs than in total 
RNA, as would be expected if they were enriched by immunoprecipitation and amplification 
steps.  This makes it unlikely that any false positives were generated by the classification 
scheme described above.  Furthermore, examination and comparison of the data in Tables 3 and 
4 (comparative signal levels read from the hybridized array) show that while mRNAs listed as 
associated with YY1 were invariably enriched in anti-YY1 IPs (Table 3), those listed as not 
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associated (Table 4) were present in YY1 IPs at levels < 30% of their levels in total RNA.  It is 
extremely unlikely that any phenomenon other than direct interaction with YY1 and 
immunoprecipitation with anti-YY1 antibody could result in some RNAs being enriched in YY1 
IPs to levels in excess of ten times that in total RNA whilst others are present at less than 10% 
of that in total RNA.  Confirmation of this reasoning was obtained by Real-Time PCR analysis 
of immunoprecipitated RNA, which confirmed relative levels of mRNA determined by RIP-
CHIP analysis (Figure 19).  Ultimately, application of advanced bioinformatic analysis to the 
data will address important questions, such as determination of common structural features of 
YY1 bound mRNAs, and better classification of these mRNAs into functional groups.  
However, the data discussed above show the current analysis is sufficient to conclude that YY1 
associates with a subset of maternally transcribed mRNAs; in particular, mRNAs which are not 
translated in the oocyte and are recruited later in development, consistent with the hypothesized 
roles in mRNA storage and regulated translation. 
4.4 RIP-CHIP analysis of YY1-Containing mRNPs –YY1-mRNPs (Table 3) contained 
mRNA transcripts encoding proteins with a vast array of cellular functions.  Transcripts 
encoding ribosomal proteins, cell cycle control, signalling, and histone proteins comprised the 
most prominent groupings, representing ~14% of the transcripts identified in the YY1-mRNP 
pool.  The remaining ~86% of transcripts encompassed an extremely varied population.  A 
number of transcripts encoding ribosomal proteins were observed including L4, L4b, L5, L7a, 
L8, L9, L12, L13, L13a, L15, L19, L22, L24, L27, L30, L35a, S1, S1a, S6, S8, S9, S10, S11, 
S12, S13, S14, S19, S21, and S27.  This suggests a possible role for YY1 in regulation of 
ribosome biosynthesis during embryogenesis. This is particularly interesting since YY1 is 
involved in transcriptional regulation of ribosomal protein expression (De Rinaldis et al., 1998; 
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Perry, 2005; Pisaneschi et al., 1994; Voronina et al., 2008), suggesting YY1 regulates ribosome 
biosynthesis at both a transcriptional and a translational level.  YY1 also associated with 
mRNAs for a number of Cyclin mRNAs, including Cyclins A1, A2, B1, B2, B3, B4, B5, and 
E3; as well as transcripts coding for important cell cycle control proteins such as Spindle 
Checkpoint protein Bub1, Ras, Rab11B, C-mos, Cdc25A, Cdk9, and Cdc45.  These 
observations correlate with data indicating YY1 plays an important transcriptional role in cell 
cycle control (Gordon et al., 2006; Palko et al., 2004; Petkova et al., 2001; Shi et al., 1997; Sui 
et al., 2004), and suggest that, at least in the oocyte and early embryo, YY1 may contribute to 
cell cycle regulation through non-transcriptional mechanisms.  YY1 also bound to several 
transcripts for histone proteins such as H4, H1A, H1.B4, H3.3A, H3.3B, and H2A.z, and again, 
this correlates with data showing regulation of histone expression by YY1 at a transcriptional 
level (Eliassen et al., 1998; Horvath et al., 2003; Last et al., 1999; van der Meijden et al., 1998; 
Wu and Lee, 2001).  Transcripts encoding protein products involved in intracellular signalling 
cascades were also associated with YY1, including the Wee1A kinase, Casein Kinase Iε, Polo-
like kinase, brain-specific Casein Kinase, and Protein Phosphatase 1G-γ, and Insulin-like 
Growth Factor Receptor 1β.     
YY1 associates with many tissue- and organ- specific transcripts which are not 
expressed in the oocyte or during the very early stages of embryogenesis, supporting the 
hypothesis that these transcripts are stored and selectively utilized later in development.  
However, YY1 also bound many transcripts associated with basic cellular functions, including 
transcripts for cytoskeletal proteins such as Alpha-/Beta-tubulin, components of basic metabolic 
pathways such as Glutamine Synthetase, Citrate Synthetase, and proteins of the mitochondrial 
ATP Synthetase complex. These data make it impossible to speculate as to whether YY1 
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associates (and possibly regulates) the targeted translation of specific stored mRNAs in specific 
tissues or is instead a general component of mRNPs which associates with many mRNAs which 
are utilized during subsequent embryonic development. 
The data acquired from microarray analysis of YY1-associated mRNAs revealed several 
trends.  Among the 119 transcripts not associated with YY1-mRNPs, 12 were products of the 
mitochondrial genome, while, importantly, no mitochondrial transcripts were found among 
transcripts identified as components of YY1-mRNPs.  This finding is consistent with previous 
work in Xenopus oocytes showing that only transcripts of nuclear origin are targeted for storage 
in mRNP particles (Braddock et al., 1994; Minshall and Standart, 2004; Smillie and 
Sommerville, 2002; Smith and Richter, 1985; Weston and Sommerville, 2006).  Also notable 
among the pool of mRNAs not associated with YY1 were transcripts for proteins expressed 
specifically in the oocyte, including Vitellogenin Receptor, the Xenopus Zona Pellucida 
Glycoprotein homologue, Synaptosomal-associated Protein, Beta-Catenin, oocyte-specific 
Elongation Factor-1α isoform, Condensin-II non-SMC subunit, Wnt-11, and Sec61γ (Table 4).  
The absence of these transcripts in anti-YY1 immunoprecipitates is consistent with the view that 
mRNPs store mRNAs required for later development. Since the above transcripts are actively 
translated to provide protein products required in the oocyte, it fits with accepted views of mRNP 
function that they be excluded from the mRNP pool, specifically, that mRNPs contain mRNAs 
destined for long-term storage rather than immediate translation. The observation that 
mitochondrial transcripts and mRNAs for proteins expressed abundantly in the oocyte are not 
present in YY1 immunoprecipitates provides convincing evidence that the RIP-CHIP analysis 
undertaken here is able to accurately differentiate transcripts associated with YY1-mRNPs from 
those that are not. 
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The major finding of this study remains the discovery of YY1 RNA-binding 
activity and its role in YY1-mRNP association.  It is clear that YY1 associates with a subset of 
the maternal mRNA pool, specifically, nuclear transcripts which are not expressed in the oocyte 
but are instead stored for use later in development.  The RIP-CHIP data presented here are in 
need of further statistical refinement before they can be used to determine a definitive profile of 
transcripts in the YY1-mRNP pool.  However, viewed with some conservatism these data are 
useful in guiding testable hypotheses with regard to the biological function of YY1-RNA 
complexes.  To determine a biological function means that one must show that a particular 
protein or its activity is required for a particular biological process.  This evidence is lacking in 
the case of YY1, since neither RNA-binding nor mRNP association of YY1 has been definitively 
linked to any particular biological process.  This issue is discussed with the understanding that 
neither the RNA-binding nor mRNP-association of any of the known mRNP proteins has been 
tied to any biological process.  A review of the literature reveals that while the biochemical 
properties of these proteins have been studied in relative detail, their role in development is 
largely unknown.  Although the literature vaguely describes the role of these proteins as “mRNA 
storage” or “regulators of translation” neither of these functions has been demonstrated in vivo 
(Bouvet et al., 1995; Bouvet and Wolffe, 1994; Braddock et al., 1994; Dreyfuss et al., 2002; 
Graumann and Marahiel, 1998; Ladomery et al., 1997; Lieb et al., 1998; Marello et al., 1992; 
Marnef et al., 2009; Matsumoto et al., 2000; Matsumoto et al., 1996; Minshall and Standart, 
2004; Minshall et al., 2001; Moore, 2005; Smillie and Sommerville, 2002; Standart and 
Minshall, 2008; Tanaka et al., 2006; Weston and Sommerville, 2006; Yang et al., 2006; Yurkova 
and Murray, 1997).  It is clear, however, that the oocyte contains numerous mRNAs that code for 
proteins utilized in later development (Table 3), and since these mRNAs are associated with 
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mRNPs it stands to reason that these complexes must have a role in their selective recruitment at 
the appropriate developmental stage and location. As with other mRNP proteins, precise 
determination of this role has heretofore been hampered by a lack of knowledge as to what 
biological processes one should look for as evidence of a role of YY1 RNA-binding.  
Determination of the mRNA substrates of YY1, described here for the first time, will facilitate 
examination of the role of YY1-mRNPs in specific cellular processes and in distinct 
developmental events. 
5. Future Work – Ongoing bioinformatic analysis of the RIP-CHIP data will 
determine common structural, sequence, and functional characteristics among YY1-associated 
mRNA molecules.  The data presented here allow testable hypotheses to be formulated regarding 
the role of YY1 RNA-binding in mRNPs as related to key developmental and cellular processes.  
Suggested future work would involve a number of experimental approaches.  Using 
immunoprecipitations and Real-Time PCR, the association of selected mRNAs with YY1 can be 
examined at specific stages of embryonic development.  This will determine if and when tissue-
specific mRNAs are mobilized from the mRNP pool.  These observations can be correlated with 
expression of the associated protein products by Western blotting.  Experiments involving 
embryo explants, in which differentiation can be experimentally controlled, will allow evaluation 
of the putative role of YY1-mRNPs in development of specific tissue types.  Modulation of 
development by exogenous application or expression of key signalling molecules in the embryo, 
such as Wnt and BMP family members, followed by investigation of their effects on YY1-
mRNPs, using the IP/Real-Time PCR approach, will determine the role of these complexes in 
key differentiation and patterning events.  Other experiments could involve overexpression of 
YY1 in embryos or injection of function-blocking anti-YY1 antibodies and subsequent 
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quantification of levels of selected YY1-associated mRNAs and their protein products.   This 
type of analysis of the effect of YY1 on the stability and translation of its mRNA substrates in 
mRNPs will finally allow direct observation of the role of YY1 in mRNPs during embryonic 
development.  One example of the many hypotheses that have arisen from the current data, and 
the methods that could be used to determine its validity is as follows: YY1 has been shown to 
affect neural patterning in Xenopus (Kwon and Chung, 2003) but the precise mechanism for this 
effect remains elusive.  Interestingly, Brain specific Casein Kinase II mRNA was identified as a 
substrate of YY1 in the current study.   Other studies have shown CKII affects anterior-posterior 
neural patterning via its action on the Snail-1 protein (MacPherson et al., 2010; Thisse et al., 
1993).  It is possible that translational regulation by YY1 of brain specific CKII would affect 
anterior-posterior neural patterning via modulation of Snail-1 by brain specific CKII, a 
hypothesis that can now be tested experimentally.   
YY1 is the first mRNP protein for which in vivo substrates have been identified, 
and the foregoing example illustrates the extreme utility of such knowledge in planning future 
experiments that will ultimately allow the precise role of YY1 in development to be determined.  
Additionally, extension of the RIP-CHIP approach to the other known mRNP proteins will 
facilitate development of stoichiometric models of mRNP composition and definitive patterns of 
maternal mRNA storage and mobilization in early development.   
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